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ABSTRACT
The goal of the current study was to gain knowledge of 
the impact that dietary compliance has on quality of life 
for end-stage renal disease patients receiving chronic in­
center hemodialysis. As a result of this type of research, 
health care professionals may better understand the 
individual and collective influence that various aspects of 
dietary compliance have on quality of life. This knowledge 
may be helpful in making future recommendations about the 
necessity of the dietary regimen.
This study investigated the relation between three 
commonly employed physiological parameters of dietary 
compliance (blood urea nitrogen, potassium, and inter­
session weight gain) and four measures of quality of life 
(Quality of Life Index, Personal Resource Questionnaire, 
Karnofsky Activity Scale, and Psychological General Well- 
Being Schedule). Also, the influence of relevant 
medical/demographic characteristics (age, age beginning 
dialysis, years on dialysis, and number of diagnoses) was 
examined. Subjects in the study included 67 hemodialysis 
patients from a university hospital dialysis center in a 
large southern city.
Correlational procedures, multiple regression analyses, 
and a canonical correlation were employed to investigate the 
association between dietary compliance, medical/demographic 
variables and quality of life. In general, the results
vi
suggested that the dietary compliance variables have little 
impact on quality of life. This finding provided further 
support for the loosening of dietary restrictions. 
Medical/demographic variables, however, were modestly 
correlated with one quality of life variable, activity. 
Knowledge about relevant medical demographic characteristics 
suggest that high risk patient profiles may be developed for 
early identification of patients who may benefit from 
rehabilitation. One problem noted in this study is the 
difficulty in defining and measuring the construct of 
quality of life.
vii
INTRODUCTION
End-Stage Renal Disease (ESRD) is a life-threatening, 
and costly health problem for a large number of individuals 
(Fisher, 1983). Until the early 60's, patients with ESRD 
had few treatment alternatives, and most died (Norton,
1982). Since that time, hemodialysis has become a standard 
treatment procedure, and the number of patients surviving 
and requiring long-term dialysis has increased (Stewart, 
1983; Wauters, Hunziker, & Brunner, 1983). One factor that 
has contributed significantly to this increase has been the 
decision by the United States Congress in 1972 to pay for 80 
percent (Fisher, 1983) of the cost of dialysis. For 
instance, in 1972, 11,000 persons were treated compared to
73,000 persons in 1982. Alternatives to dialysis are 
available (e.g., renal transplant and peritoneal dialysis), 
but are appropriate for only a minority of patients 
(Wauters, et al., 1983). Hemodialysis remains the most 
accepted and widely used method of treatment (Hirschman,
Wolfson, Moseman, Clark, Dante, & Wineman, 1981). Although 
hemodialysis can prolong patient survival, it does not 
assure a high quality of life to the patient, particularly 
since dialysis treatment is followed by a number of physical 
and psychological sequelae as well as the necessity of 
living with a strict and complex regimen. This paper will
1
2examine the relevant issues in renal failure, including 
medical and psychological complications, quality of life, 
and compliance. At the end of this paper, a study will be 
proposed to examine the relation between quality of life and 
compliance with the dietary regimen.
End Stage Renal Disease
Two types of renal failure exist: acute and chronic 
(Cameron, Russell, & Sale, 1976). Acute renal failure is 
distinguishable from chronic renal failure by its rapid 
onset and usually reversible nature (Stein, 1985: schripr 6 
Conger, 1980). Chronic renal failure results from a 
progressive and usually irreversible reduction in working 
nephrons (Kokko, 1985; Cameron et al., 1976; Alfrey, 1980). 
For the purposes of the present study, only chronic renal 
failure will be considered.
Chronic xenal failure (CRF), a functional diagnosis, 
can result from any number of diseases that irreversibly 
destroy the nephrons and consequently cause glomerular 
filtration rate (GFR) to decline. GFR is a measure of the 
kidneys' ability to remove a substance (e.g., urea) from the 
bloodstream. In a study of 1049 patients on chronic 
hemodialysis, Hirschman et al. (1981) reported that roughly 
30 percent of their patients required dialysis due to 
glomerulopathies, 19 percent to unknown causes, 13 percent 
to kidney disease, 7 percent to diabetes, 3 percent to 
vascular disorders, and 5 percent to miscellaneous causes.
3Their findings are similar to those reported by other 
investigators (e.g. Kokko, 1985).
Many times there are no clinical manifestations of a 
renal problem until irreversible damage has occurred (Kokko, 
1985; Wright, 1981; Cameron, et al., 1976). This is not 
surprising when one considers that most patients are 
asymptomatic until they have lost 90 to 95 percent of their 
renal function. A patient with progressive renal failure 
goes through four stages (Knochel & Seldin, 1981) . In the 
first stage, the concentration of urea nitrogen and 
creatinine rises abnormally, however, the kidneys continue 
to excrete and regulate substances quite well with no 
symptoms noted by the patient. In the second stage of renal 
failure there is renal insufficiency, which is manifested by 
increased nitrogen in the bloodstream (azotemia), frequent 
urination at night, mild anemia, and impaired ability to 
concentrate urine. In the third stage of renal failure, a 
number of derangements are seen in the body's regulatory and 
excretory functions, including a worsening of the symptoms 
found in stage two. The final stage of renal failure is 
uremia or the "uremic syndrome".
Uremia. Uremia has been called "urine in the blood". This 
implies that substances that are normally filtered out of 
the blood are retained and that the body is poisoning itself 
with the toxins that should have been removed. Uremia 
disrupts every system in the body, and complications are
4manifest in a number of ways (Kokko, 1985; Alfrey, 1981). 
Water and electrolyte abnormalities, including imbalances in 
potassium, sodium, calcium, chloride, magnesium, and 
phosphorus are present. Gastrointestinal complications of 
uremia (e.g., nausea, vomiting, and anorexia) are extremely 
common. Cardiovascular abnormalities are present. These 
include hypertension, hypertriglyceridemia (elevated 
triglyceride concentration in the blood), pericarditis 
(inflammation of the membrane around the heart), and 
increased mortality due to heart failure. The most common 
hematological abnormality is anemia. Skeletal changes 
associated with uremia include osteitis fibrosa 
(inflammation of the bone accompanied by replacement of bone 
tissue with fibrous tissue), Osteomalacia (softening and 
bending of bones), osteoporosis (reduction in the quantity 
of bone or atrophy of skeletal tissue), and osteosclerosis 
(abnormal hardening of the bone). Symptoms experienced by 
the patient include bone pain and fractures. Neuromuscular 
abnormalities are present and are associated with some of 
the earliest signs of CRF. Psychological and neurological 
problems include altered mental status, depression, 
psychosis, anxiety, headaches, and sleep disturbance. 
Peripheral neuropathies, including muscle weakness, muscle 
twitches and spasms, and parathesias may be present. 
Infections are common in uremic patients, probably due to a 
suppressed immune system. Carbohydrate metabolism is
5altered; in particular, glucose tolerance is impaired. 
Finally, a common complication is generalized pruritus 
(itching). Although this list does not exhaust all the 
complications found in uremia, it provides a basic 
description of the extent to which uremia disrupts normal 
body function. For more detailed information, the reader is 
referred to Kokko (1985) and Alfrey (1980).
Treatment. Chronic renal failure can be managed in three 
ways: conservative management, transplantation, and dialysis 
(Norton, 1982; Wright, 1981). Conservative management is 
usually the step taken when nothing can be done to stop the 
progression of renal failure and before either dialysis or 
transplantation is initiated. The patient is observed and 
monitored closely. Dietary restrictions are initiated, 
including calorie, protein, sodium, potassium, fluid, and 
calcium restrictions. After conservative management is no 
longer effective, decisions are made about the next step in 
treatment. Transplantation of a kidney from either a 
relative or cadaveric donor is an effective treatment and 
results in a higher quality of life than dialysis (Kokko, 
1985; Wolcott, & Nissenson, 1988; Johnson, McCauley, & 
Copley, 1982. Unfortunately, it is not feasible in many 
cases because of poor medical status or because a suitable 
donor is not available. Therefore the treatment of choice 
for most patients is dialysis (Kokko, 1985; O'Brien, 1980).
Two types of dialysis are available: peritoneal
6dialysis and hemodialysis. In peritoneal dialysis, the 
peritoneal membrane in the abdomen is used as the 
semipermeable membrane through which substances are 
dialyzed. This procedure is simple and requires few 
specialized personnel and equipment; however, 24 to 4 8 hours 
are needed to remove toxins. Since the present study is 
restricted to patients receiving hemodialysis, the 
hemodialysis procedure will be described in greater detail.
The history of hemodialysis began in 1913 when three 
physicians used dialysis to experiment with a living animal 
(Longo, 1981). The method was primitive by today's 
standards, for example, leeches were ground to make the 
anticoagulant. Nevertheless, the point was made that 
certain unwanted substances could be removed from the 
bloodstream by passage through a semipermeable membrane. 
Hemodialysis refers to a procedure in which a machine 
removes from the bloodstream a variety of toxic substances 
that are normally removed by the kidneys and excreted in 
urine (Luke, 1985; Finn & Alcorn, 1986). Blood is routed 
out of the body via a vascular access (shunt, cannula, or 
fistula) and into an "artificial kidney". The artificial 
kidney is a machine comprised of channels bounded by 
membranes. The membranes are permeable to metabolic waste 
products from the blood while restoring water, electrolytes, 
and acid-base balance (Man and Jungers, 1982). Cleansed 
blood returns to the body via the vascular access (Norton,
71982). The dialysis procedure lasts a few hours and 
typically is performed on alternate days. The actual time 
required for dialysis depends upon the type of machine used 
and the physical status of the patient. The survival rate 
for dialysis patients has increased significantly since 
dialysis first was used as a treatment modality (Bradley, 
Evans, and Caine, 1987; Cameron et a l ., 1976) Research 
indicates that the three year survival rate is 85 percent 
for patients between the ages of 20 to 25 and 60 percent for 
those between the ages of 60 and 65 (Luke, 1985). Maker and 
Curtis (1987) reported that actuarial survival rates for 174 
patients (aged less than 55 at the beginning of the study) 
were 69 percent, 52 percent, and 38 percent at 5, 10, and 15 
years respectively. Rosensky and Eggers (1987) reported 
that despite the increase in older and sicker patients from 
the period of 1974 to 1979, survival rates remained stable 
and even improved for the older patients. This stability 
and improvement was thought to reflect improvements in care. 
Although patients on dialysis can survive, the artificial 
kidney does not completely substitute for the normal kidney 
and does not perform the excretory and regulatory functions 
as efficiently as the normal kidney does. These 
deficiencies lead to a variety of restrictions to lifestyle 
(Cameron et al., 1976; Kutner, Fair, & Kutner, 1985). 
Consequently, further discussion of these restrictions is 
warranted.
8Dialysis Treatment Regimen
The medical regimen recommended for all dialysis 
patients is designed to avoid the complications associated 
with dialysis (Ginn & Teschin, 1983) . Treatment requires 
frequent dialysis to remove metabolic waste products and to 
control fluid volume. Also, nutritional management is 
necessary to reduce metabolic by-products, electrolytes, 
minerals, and fluids that accumulate between dialysis 
sessions as well as supplement lost substances such as 
vitamins and minerals (Kluthe, 1983; Burton, 1974). 
Malnutrition and wasting are frequently seen in dialysis 
patients and can contribute to increased incidence of 
infection and increased morbidity. Although exact dietary 
requirements are dependent upon patient characteristics, 
such as age, weight, sex, occupation, and duration and 
frequency of dialysis, a number of general principles are 
known (Cameron, et al., 1976; Rodriguez & Hunter, 1981). 
First, protein intake must be limited in order to reduce the 
amount of blood urea nitrogen (BUN) that accumulates in the 
bloodstream, and thereby reduces the number of uremic 
symptoms (Kokko, 1985; Finn & Alcorn, 1986). BUN is a waste 
product that accumulates from the breakdown of protein. 
However, too little protein intake can lead to loss of 
strength, body weight, and muscle mass.
Sodium and potassium are restricted. Excessive sodium 
can lead to swelling and hypertension. The amount of sodium
9allowed in the diet is dependent upon the patient's blood 
pressure (Rodriguez & Hunter, 1981; Cummings, Becker, 
Kirscht, & Levin, 1982). Usually sodium is restricted to 2 
to 4 grams daily; however in a patient who has no symptoms 
of hypertension or fluid overload, sodium restriction may be 
liberalized. Potassium is an element that is not 
effectively dialyzed and has to be limited to 45 to 70 mg/kg 
per day. Hyperkalemia, a greater than normal concentration 
of potassium ions in the bloodstream, can lead to cardiac 
arrhythmias and death.
Phosphorus levels are controlled to prevent the 
development of osteodystrophy (Coburn and Llach, 1983). 
Phosphate binders are given to control the amount of 
phosphorus that is absorbed into the bloodstream from the 
intestinal tract. As renal function deteriorates, the 
quantity of phosphate binders required to control the 
phosphorus levels increases.
Fluid intake must be carefully monitored and controlled 
to keep pace with the kidney’s ability to eliminate fluid 
(Cummings, Kirscht, Becker, & Levin, 1984). The 
consequences of fluid overload are serious and include 
edema, hypertension and heart failure. Also, inter-session 
fluid gain usually means that the patient will experience a 
distressing dialysis session with nausea, vomiting, and 
dizziness (Rostand & Rutsky, 1984). The need to limit fluids 
is probably the most difficult restriction (Rodriguez and
10
Hunter, 1981).
Although a variety of substances must be restricted, 
some lost as a result of dialysis (Luke, 1985; Finn &
Alcorn, 1986). Water soluble vitamins are lost from the 
bloodstream during dialysis and must be replaced by routine 
administration of vitamin supplements. This supplementation 
is also necessary because many of the fruits and vegetables 
providing these vitamins are restricted. Vitamin K is given 
to the patient when taking antibiotics. Iron supplements 
required are since dialysis patients are frequently anemic. 
Another element that the dialysis procedure removes is zinc. 
Zinc deficiency leads to decreased taste sensitivity as and 
decreased appetite.
Medical Complications of Dialysis
Patients on maintenance dialysis require ongoing 
medical attention for a variety of iatrogenic complications, 
persistent uremia, and physical problems such as diseases of 
the cardiovascular system, hematologic system, skeletal 
system, gastrointestinal problems, infections, and 
neurological disorders (Luke, 1985; Wright, 1981). Many of 
the complications were mentioned in the section on uremia as 
complications of uremia. Generally, the problems are more 
severe during the uremic phase, then become chronic problems 
associated with repeated dialysis.
Iatrogenic Effects of Dialysis. The dialysis session may be 
complicated by episodes of hypotension, muscle cramps, and
11
by problems with anticoagulation. Hypotension refers to a 
drop in blood pressure and is experienced by the patient as 
dizziness, malaise, nausea and vomiting, and unexplained 
anxiety. Hypotension appears to be related to too rapid 
removal of fluid and/or excess fluid. Muscle cramps are 
common both during and between dialysis sessions. They are 
thought to result from too rapid removal of extracellular 
fluid which induces altered concentrations of sodium in the 
muscle cell. Anticoagulants are used to prevent clotting of 
the vascular access. A significant complication of this 
medication is spontaneous bleeding in the gastrointestinal 
tract, pericardium, pleura, joints, retroperitoneal space, 
and cerebrum (Butt, 198 3).
Cardiovascular Complications. Cardiovascular problems are 
some of the leading causes of morbidity and death in 
dialysis patients (Wright, 1981). Comty and Shapiro (1983) 
reported that at the end of a 13 year study (with patients 
selected for their absence of vascular disease) 60 percent 
of deaths could be attributed to cardiovascular 
complications: hypertension, arteriosclerotic cardiovascular 
disease, congestive heart failure, and pericarditis.
Hypertension is the most common cardiovascular disorder 
in CRF, and its control is essential to longevity for 
dialysis patients as it is a predisposing factor in a number 
of cardiovascular disorders (White & Rubin, 1983; Wright, 
1981). Approximately 80 percent of CRF patients have
12
hypertension when they begin a program of dialysis. It 
usually resolves after dialysis, but, is a recalcitrant 
problem for approximately 5 to 30 percent of patients. 
Treatment of this disorder in CRF patients is consistent 
with traditional hypertensive regimens and is done in a 
stepwise fashion. Salt and fluid intake is restricted. 
(Diuretics are not needed in patients with no renal output.) 
If this regimen is not sufficient to control blood pressure, 
Beta Blockers are prescribed to inhibit autonomic nervous 
system activity. Finally, for dialysis patients, a last 
alternative is a bilateral nephrectomy.
Evidence suggesting that dialysis accelerates the rate 
of vascular disease is equivocal; it does appear, however, 
that dialysis may hasten the process and increase mortality 
for patients who already have vascular disease (Burke, 
Francos, Moore, Cho, & Lasker, 1978). Vascular problems are 
most common in older patients. Typical clinical 
manifestations of vascular disease are angina, 
cerebrovascular accidents, and transient ischemic attacks. 
Treatment is similar to that prescribed for non-dialysis 
patients and does not preclude surgery if aggressive medical 
management does not succeed.
According to Comty and Shapiro (1983), congestive heart 
failure (CHF) frequently occurs in dialysis patients.
Factors contributing to CHF in the nondialysis population 
contribute to the occurrence of heart failure in the
13
dialysis patient (Wright, 1981). Dialysis patients may 
suffer from congestive cardiomyopathy (disease of the middle 
layer of the heart muscle) caused by uremia and excessive 
accumulation of fluid. Treatment of CRF then consists of 
controlling hypertension, and fluid weight gain, conditions 
known to increase the cardiac workload. Treatment may also 
involve the use of vasodilator drugs and by-pass surgery. 
Pericarditis is a life-threatening complication of terminal 
uremia, and may continue to be a problem for long-term 
dialysis patients (Comty and Shapiro, 1983). Signs and 
symptoms of pericarditis are chest pain, fever, and 
compression of the venous return to the heart due to 
increased fluid volume in the pericardium (cardiac 
tamponade; Wright, 1981). Pericarditis is likely to occur
during the first 2 months of dialysis treatment. Management
consists of bedrest, maintenance of adequate nutrition, 
improving biochemical control of uremia through dialysis, 
restricting protein and fluid, preventing bleeding by 
decreasing the use of anticoagulants, and adding anti­
inflammatory drugs to the regimen.
Hematologic Complications. Anemia develops in almost all 
CRF and dialysis patients (Eschbach, 1983). The kidneys 
reduce red blood cell mass by producing the hormone 
erythropoietin which stimulates the production of red blood 
cells in the bone marrow. Anemia can result from 
insufficient erythropoietin production. Another cause of
14
anemia is blood loss, ranging from 15-75 ml, which occurs 
with each dialysis session. Additional losses occur from 
blood samples required for various lab tests. Folic acid, a 
member of the vitamin B complex and necessary for red blood 
cell production is removed during dialysis. All those 
factors contribute to anemia in the dialysis patient. 
Treatment consists of either or both of two methods: iron 
supplementation and blood transfusion.
Renal Osteodystrophy. The term renal osteodystrophy is used 
in a generic sense to include all clinical syndromes of 
skeletal disease and altered calcium and phosphorus 
metabolism (Coburn & Llach, 1983). Vitamin D metabolism is 
altered due to the kidney's inability to produce the hormone 
needed to convert vitamin D into a biologically active form 
that facilitates the absorption of calcium and phosphorus.
As a result, intestinal absorption of calcium is abnormally 
low. Parathyroid hormone is secreted in response to lowered 
levels of calcium. Elevated blood levels of parathyroid 
hormone cause bone changes that lead to skeletal 
abnormalities. Some of the signs and symptoms of renal 
osteodystrophy are skeletal pain, muscular weakness, 
itching, bone deformities and growth retardation in 
children, fractures, periarthritis (acute pain, redness and 
swelling of joints), tendon rupture, ulceration of the skin, 
and altered biochemistry. Medical management consists of 
suppressing parathyroid hormone, and maintaining proper
15
blood concentrations of calcium, magnesium, and phosphorus, 
using dietary restrictions of phosphorus-containing foods, 
and dietary supplements of calcium, vitamin D therapy, and 
as a last resort, a partial parathyroidectomy. 
Gastrointestinal Complication. Ten to fifteen percent of 
dialysis patients tend to have gastritis and duodenitis 
(without ulcers) causing gastric pain and "heartburn** 
(Wright, 1981). They do not generally experience the nausea 
and vomiting experienced by uremic patients, except 
occasionally during the dialysis procedure.
Infection. Frequent infections pose a major medical problem 
for dialysis patients (Keane & Raij, 198 3; Mosely, Brantley, 
Jones, & Cocke, in press). The infections found are not rare 
or unusual, but dialysis patients are repetitively exposed 
to infection during the dialysis procedure. Contributing to 
infection in most patients is a compromised immune system 
and poor nutritional status.
Infection is a leading cause of death in dialysis 
patients with estimates ranging between 14-38 percent. The 
major infectious complications are access infections and 
thrombosis as a result of infections at the access site, 
pulmonary emboli caused by infection at the access site, 
bacterial endocarditis, osteomyelitis, bacteremia (the 
presence of viable bacteria in the bloodstream), septic 
arthritis, urinary tract infections, respiratory infections, 
and hepatitis (Palakoff, 1983; Butt, 1983) .
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Neurological Disorders. Neurological disorders are another 
frequent complication in dialysis patients (Jennekins, & 
Jennekins -Schinkel, 1983). Some of these complications 
result from the persistent slight uremia. Usually some 
encephalopathy is present. "Dialysis Dementia", a 
progressively fatal complication occurs in patients who have 
received dialysis for a number of years (Luke, 198 5; Wright, 
1981). It is a central nervous system disorder associated 
with speech and motor defects, dementia, and seizures. It 
is less common now than in years past, probably as a result 
of improved methods of dialysis. Intracerebral hemorrhage 
may occur as a complication of the anticoagulants used 
during dialysis. Multi-infarct dementia may be present, 
particularly in patients with hypertension. Peripheral 
neuropathies are some of the principal and most frequent 
neurological manifestations. The neuropathy of uremia is 
similar to that found in patients with diabetes. The most 
common complaint is an uncomfortable feeling in the legs 
that is relieved by movement, known as "restless leg 
syndrome". Burning and tingling in the extremities may also 
be present.
Other neurological complications associated with the 
dialysis session result from severe azotemia (increased 
nitrogen in the bloodstream). Onset of symptoms usually 
occurs near the end of the session. This is called the 
Dialysis Disequilibrium Syndrome and is characterized by
17
headache, nausea and vomiting, blurred vision, 
disorientation, restlessness, and muscle cramps (Jennekins 
and Jennekins-Schinkel, 1983; Longo, 1981; Salmons, 1980). 
More severe manifestations of this syndrome include 
confusion and convulsions.
Psychological Complications of Dialysis
End-stage renal disease and concomitant dialysis 
therapy is a catastrophic and permanent change that 
significantly disrupts lifestyle and requires major life 
adjustments (Burton, Kline, Lindsay, & Heidenheim, 1986).
As the patient gets sicker, progressing from a renal patient 
to a dialysis patient, more difficult restrictions, crises, 
and threats of personal loss occur. The patient must come 
to terms with disability and limitations created by the 
illness (Salmons, 1980; Ginn & Teschen, 1983).
Coping Styles. Many of the psychological stresses and 
problems that occur during dialysis are inherent in the 
situation. Some of the earliest work done by Kaplan De Nour 
and Czaczkes (1972) indicated that dialysis patients have 
high levels of aggression and an inability to openly express 
this aggression. Other factors that were identified were 
low frustration tolerance, the tendency to act out, denial 
of the sick role, secondary gain from the sick role, and 
self-destructive tendencies. Stewart (1983) discussed the 
prevalence of defense mechanisms, such as denial, 
displacement, isolation, projection and reaction formation.
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In his analysis, denial is the most frequently used defense 
against the stress of chronic illness. Also, he emphasized 
patient dependency and regression with successful adaptation 
to dialysis. This does not mean that there is a "dialysis 
personality", but rather that the stress of dialysis brings 
out similar coping styles in patients. It would also be 
expected that some patients may have even more difficulty 
coping and may develop clear-cut psychological problems. 
Depression. One problematic and common psychological 
presentation in dialysis patients is depression (Burton et 
al., 1986). Stewart (1983) estimated that at any one time 
at least a quarter of the patients on a dialysis unit will 
report signs and symptoms of major depression. Burton et 
al. (1986) reported that approximately 60 percent of 
patients in their sample were severely depressed. In general 
depression occurred more frequently and with greater 
severity in the dialysis population than in the non-dialysis 
population. Abram, Moore, and Westervelt (1971) reported 
that the suicide rate for dialysis patients was 100 times 
greater than that in the average population. If patients 
who had requested withdrawal from treatment were included in 
this estimate, the rate would increase to 400 times that of 
the non-dialysis population.
Anxiety. Anxiety is another common presentation of dialysis 
patients (Salmons, 1980). Nearly all dialysis patients 
experience anxiety at one time or another, since the threat
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of imminent death is a real one. For some, anxiety may be 
episodic and short-lived and respond well to reassurance and 
support. For others, hemodialysis may lead to full-blown 
panic attacks (Salmons, 1980).
Sexual Dysfunction. Sexual dysfunction is another 
distressing problem for dialysis patients. This may be 
experienced as decreased libido, problems with erection, or 
problems with ejaculation. Stewart (1983) reported that 
prior to dialysis, 45 percent of male patients develop 
impotence secondary to uremia. After dialysis has been 
initiated, an additional 35 percent will develop impotence. 
Impotence appears to be correlated with psychological 
problems; organic factors, however, play an important part. 
Low blood zinc and testosterone levels, elevated parathyroid 
hormone, and neuropathies have been found to be related to 
impotence. Female dialysis patients also report sexual 
difficulties, but less is known about their problems. Sexual 
performance for both male and female dialysis patients may 
be impaired by poor physical health, anxiety, depression, 
the side -effects of medications, and organic factors. 
Dementia and Psychosis. Organic and functional factors 
interact and can cause disruption in cognition and awareness 
(Salmons, 1980). Uremia, hypertension, anemia, cardiac 
complications, infection and metabolic abnormalities can 
effect cerebral function. Memory and abstract thought 
processes tend to deteriorate slowly. Other intellectual
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abilities also tend to deteriorate slowly. In the past, it 
was not uncommon for patients maintained by dialysis to 
develop a progressive dementia accompanied by personality 
changes, such as apathy, irritability, and temper outbursts, 
frequent drowsiness, and fatigue. Improved methods of 
dialysis have brought about a significant decline in this 
"dialysis dementia". Psychotic states, accompanied by 
delusions and hallucinations, may be present in the dialysis 
patient. Most reported cases of psychosis are related to 
organic factors, such as a steroid psychosis or uremia, 
however, there are some reports in the literature of 
patients with a longstanding history of manic-depressive 
psychosis or schizophrenia prior to their beginning 
dialysis. These patients represent an especially difficult 
subpopulation of dialysis patients.
Noncompliance. Generally, compliance refers to the degree 
to which the patient's behavior coincides with prescribed 
medical or health advice (Haynes, 1982). Compliance with 
the medical regimen may involve relatively simple behaviors, 
such as keeping a physician's appointment or getting a chest 
x-ray or very complex behaviors, such as monitoring caloric 
intake and urine or blood glucose several times a day for a 
lifetime (Turk, Salovey, & Litt, 1986) . An appropriate 
definition of compliance will obviously reflect the nature 
of the health problem for which treatment is being 
sought. Dialysis "patients are confronted with the
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prospect that they cooperate continuously for an indefinite 
time, with treatment that is costly in terms of time, 
thought... [and] effort. Their regimen denies them many of 
the "normal means of
coping ", such as eating, the use of tranquilizers and 
alcohol, sexual outlets, and physical exercise" (Ginn & 
Teschen, 1983). Also, their regimen is one of the most 
complex and demanding of all regimens, meaning that it is 
also one of the most difficult to follow (Nehemkis & Gerber, 
1986; Eraker, Kirscht, & Becker, 1984; Masur, 1981; Stone, 
1979). General compliance for the dialysis patient can be 
defined as: 1)compliance with nutritional management, 
including dietary and fluid restrictions, 2)general 
compliance with medical recommendations (i.e. taking 
medicine), and 3)the decision to continue dialysis rather 
than terminate treatment against medical advice (Kaplan De 
Nour & Czaczkes, 1979). Measurement of compliance with the 
dietary restrictions and with the prescribed medications has 
traditionally involved a combination of three methods.
These are health care provider assessment, patient self- 
report, and biochemical measures. Of these three methods 
the biochemical measures are done routinely, systematically, 
and are the most objective (Luke, 1985; Cummings, Becker, 
Kirscht, & Levin, 1981; Kokko, 1985).
Health care provider assessment of compliance is the 
most frequently used clinical measure and has been used as a
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supplemental measure in research (Roth, Caron, & Hsi, 1970). 
These ratings are usually based upon a review of the 
biochemical measures and can actually be considered a 
combination rating. Research has indicated that health care 
professionals tend to overestimate compliance and are able 
to predict compliance only at about chance levels (Becker, & 
Rosenstock, 1984). Therefore, sole reliance on this 
technique for research purposes has not been recommended.
Patient self-report measures usually involve a patient 
interview or self-monitoring or both. The interview is 
probably the most common method to obtain patient self- 
report (Kaplan, De-Nour and Czaczkes, 1972; Cummings et al., 
1982; Cummings et al., 1984; Sherwood, 1983). Although this 
is a very easy and economical way to obtain data, research 
has indicated that self-report is not very accurate and, 
again, is not the technique of choice for research purposes 
(Park & Lipman, 1964).
Biochemical measures are those most used in dialysis 
research and are also considered the most objective for 
research purposes (Masur, 1981; Blackburn, 1977; Cummings et 
al.,1982; Sherwood, 1983; Finn & Alcorn, 1985; Streltzer & 
Hassell, 1988). A variety of physiological measures are 
routinely taken for dialysis: blood urea nitrogen (BUN), 
serum potassium levels (K), serum phosphate levels 
(SPHL), and inter-session weight gain (IWG). (For specific 
compliance criteria, please see Appendix C.)
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Demographic factors found to be related to compliance 
in dialysis patients are age, educational background, SES, 
and race (Rostand, Kirk, Rutsky, & Pate, 1982; Reiman,
1982). O'Brien (1980) found several variables associated 
with compliance: unskilled workers were less compliant than 
professionals, subjects who lived alone were the least 
compliant, and those living with other adults and children 
were the most compliant. Cummings et al. (1982), Ferraro, 
Dixon, and Kinlaw (1986) and Blackburn (1977) reported that 
those dialysis patients who had been undergoing dialysis for
longer periods of time were less compliant.
Some other factors thought to be associated with 
compliance are knowledge and understanding of the regimen. 
Research has provided equivocal results, with some studies 
finding no relation (Eraker et a l ., 1984) and others finding
a positive relation (Kaplan DeNour, & Czaczkes, 1972). 
Health beliefs have also been found to be inconsistently 
related to compliance. According to a review by Turk et al. 
(1986), some studies find that health beliefs do effect 
compliance while others find that health beliefs may be 
necessary but not sufficient conditions to improve 
compliance. Social support is another factor that has been
found to be both positively and negatively related to
compliance. Hartmen and Becker (1978) reported that 
dialysis patients with fewer family problems and more spouse 
assistance were more compliant. They also found that
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married patients were more compliant that unmarried 
patients. A final variable to consider when discussing 
compliance in dialysis patients is the complexity of the 
treatment. This factor has been very consistently and 
positively related, the more complex the regimen the greater 
the noncompliance. As was discussed in the beginning of 
this section, the treatment regimen is quite complex, 
trying, and leads to considerable hardship for dialysis 
patients (Masur, 1981; Eraker et al., 1984; Nehemkis & 
Gerber, 1982; stone, 1979).
QUALITY OF LIFE
Many of today's medical techniques can impressively 
halt and even reverse the progression of diseases that just 
a few years ago were fatal (Hollandsworth, 1988; Brennan, 
Davis, Bucholz, Kuhn, & Gray, 1987; Ganz, Haskell, Figlin,
La Soto, Siaus, 1988). As a result, many very sick 
individuals have had years added to their lives. The 
traditional medical goal has been just that - to add years, 
or to increase survival. Frequently this has been done by 
using medical techniques that are invasive, intrusive, and 
have significant negative side-effects. There are numerous 
examples of this in the literature with a wide variety of 
patient populations represented, such as heart patients 
(Evans, Manninen, Maier, Garrison, & Hart, 1985; Raczynski,
& Oberman,19;), cancer patients (Dolgin, Katz, Doctors, & 
Siegal, 1986; Slevin, Plant, Lynch, Drinkwater, & Gregory, 
1988) and end stage renal disease (ESRD) patients (Blagg, 
1985; Wolcott & Nissenson, 1988; Evans, Manninnen, Garrison, 
Hart, Blagg, Gutman, Hull, & Lowrie, 1985), to mention a 
few. The goal of survival has been attained, however, an 
important consideration is the price, in terms of quality of 
life (QL) that has been paid by patients because of the 
nature of the treatment. Consequently during the past 10 
years, both researchers and health care professionals have 
been addressing the issue of quality of life in medical 
patients.
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Unfortunately, the issue of QL is difficult to address 
since it is a multidimensional phenomenon which defies easy 
definition (Greenwald, 1987). Both researchers and 
clinicians have had difficulty agreeing on its definition 
and measurement. Efforts to define it began with President 
Eisenhower's Commission on National Goals, which published 
its report in I960 (Flanagan, 1982). For the general 
population, a variety of issues have been considered 
including: social and environmental factors, economic 
growth, health and welfare, psychologic disturbance, 
physical problems and overall happiness of the individual 
(Gurin, G . , Verhoff, J., Feld, S., 1960). Researchers have
attempted to define more specifically what they mean by QL 
(Binik & Devins, 1987; De Haes & Knippenberg, 1985). Some 
have stated that QL refers to the degree of need 
satisfaction within the physical, psychological, social, 
material and structural areas (Binik & Devins, 1987; De Heas 
& Knippenberg, 1985). Others have defined QL as a product 
of the patient's natural endowment and the efforts made on 
his/her behalf by the family and society (Andrews & Withey, 
1976). Some define QL as a global evaluation of the good or 
satisfactory character of people's lives (Campbell,
Converse, & Rodgers, 1976). Quality of Life has also been 
defined as the totality of those goods, services situations, 
and state of affairs which constitute the basic nature of 
human life (Flanagan, 1982). This list of definitions
reflects the difficulty with defining quality of life.
Measurement of quality of life has not been easy 
either, but researchers have been able to differentiate 
measurement approaches into two categories: objective and 
subjective (Hollandsworth, 1988). The medical literature 
has focused on objective measures as these are thought to 
more closely approximate "hard” measures and to be more 
scientific. Examples of objective measures include 
survival, health status, exercise tolerance, employment 
status, and medical complications (see Hollandsworth, 1988 
for an extensive list of both objective and subjective 
measures). One characteristic of the objective measures i 
that they are determined by a health care professional and 
do not simply reflect the patients' opinion.
Most recently, both the medical and the psychological 
literature have begun to emphasize the importance of the 
patients' subjective assessment of their QL. Subjective 
measures include a wide variety of self-report measures 
(e.g., Profile of Mood States, Sickness Impact Profile, 
Eysenck Personality Inventory, MMPI, Social Dependency 
Scale, etc.,...) that reflect researchers' 
conceptualizations or definitions of QL. Numerous 
instruments have been developed to assess many of the 
attributes listed previously, and frequently include such 
specifics as psychological state, social support, stress, 
and life satisfaction. The essence of the subjective
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measures is that they are supposed to reflect the patients' 
experiences as appraised by the patients.
In sum, many definitions and measures exist due to the 
lack of agreement about the meaning of QL. Despite the 
disagreement, researchers have attempted to answer relevant 
questions about the impact of medical treatment on QL. The 
typical approach to doing this has been for the researcher 
or clinician to judge which measures are appropriate for his 
or her purposes and to find those measures having adequate 
reliability and validity (Binik & Devins, 1987? Greenwald, 
1987) .
Despite the uncertainty about which dimensions are most 
suitable, there is good agreement about which diseases 
affect QL. End stage renal disease was the second most 
represented disorder in the quality of life literature 
(Hollandsworth, 1988). It is a disease with a treatment 
modality that is technologically advanced and effectively 
increases survival. Yet in many cases the treatment is 
accompanied by significant morbidity and disability that 
many researchers believe diminishes QL (Evans et al., 1985; 
Blagg, 1985; Evans, Mannien, Maier, Garrison, & Hart, 1985). 
Wolcott, Nissenson, & Landsverk, (1988) addressed the 
dilemma of defining QL by conceptualizing it in terms of 
three dimensions: medical, psychological, and social. They 
have been used by other dialysis researchers (Evans et al, 
1985; Ferrans & Powers, 1985; Binik & Devins, 1987) and by
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those studying other chronic illnesses (Raczynski &
Oberman, 198; Dolgin et a l ., 1986; Slevin et al., 1988). 
However much of the quality of life literature relating to 
ESRD patients compared maintenance dialysis patients with 
renal transplant patients or peritoneal dialysis patients, 
since the general population is not the proper comparison 
group and, these represent the alternative treatment 
regimens (Freeman, 1986; Poznanski, Miller, Salquero, & 
Kelsh, 1978; Ginn & Teschen, 1983). Therefore, a discussion 
of the various dimensions of QL thought to be relevant to 
dialysis patients is included in this report, comparing 
chronic hemodialysis patients with other ESRD patients. 
Medical. Medical measures of QL are almost always objective 
and are usually assessed by physicians and other medical 
staff. These measures include health status, functional 
status, and employment status. One commonly used objective 
measure that reflects functional status is the Karnofsky 
Activity Scale (Freeman, 1986; Poznanski, et al., 1978;
Ginn & Teschen, 1983; Carlson, Johnson, and Kjellstrand,
1987; Karnofsky and Burchenal, 1949). The Karnofsky scale 
is a 100 point scale developed to rate the functional status 
of patients at the beginning of treatment and every six 
months afterwards. Numerical scores corresponding to 
behavioral descriptors occur at each 10 point gradation of 
the scale and range from 0 (dead) to 100 (normal, no 
complaints, no evidence of disease). Carlson et al. (1987)
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found that patients who received a renal transplant had 
initial rehabilitation scores that were higher than 
rehabilitation scores of dialysis patients. Patients 
undergoing dialysis for a two-year period showed improvement 
in rehabilitation status, however they never reached the 
level of rehabilitation of the transplant patients. The 
best predictor of rehabilitation status at two years for 
both groups was rehabilitation status at the initiation of 
dialysis.
In Evans et a l . (1985) renal transplant patients and
dialysis patients were compared using the Karnofsky Scale 
and by asking patients how able they were to work for pay 
("Are you now able to work for pay full-time, part-time, or 
not at all?). They found that 79.1 percent of the 
transplant patients were able to function at near normal 
levels (as measured by the Karnofsky) compared to 47.5 
percent of the patients treated with hemodialysis. Almost 
75 percent of transplant patients were reported being able 
to work compared to 24.7 percent of hemodialysis patients.
Wolcott and Nissenson (1988) compared hemodialysis 
patients with home dialysis patients and found no 
significant differences between the groups on medical status 
variables (primary diagnosis, presence of diabetes, and the 
Karnofsky); however, their selection criteria were quite 
strict and patients in very poor health were excluded. 
Despite the restriction of range, home dialysis patients
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were more likely to be working than were hemodialysis 
patients. The authors concluded that dialysis modality 
exerts a small effect on QL.
Health status is another objective measure frequently 
used in the literature. Some overlap exist between health 
status and rehabilitation status; health status, however, 
more specifically reflects the nature and degree of organic 
pathology and those behaviors thought to be associated with 
the presence of illness such as symptom reporting, medical 
utilization, and perceptions of physical well-being. Health 
status is usually assessed through physician assessment 
(e.g., medical examination, diagnosis). Physician rating 
scales are considered the most objective, and they vary in 
their format from, global ratings to highly structured 
interviews. Patient self-ratings of health status are 
considered subjective measures and are highly correlated 
with life satisfaction (Palmore & Luikart, 1972; Kaplan and 
Camacho, 1983).
In general, successful transplant patients report better 
health status than hemodialysis patients. Renal transplant 
patients report being less tired, feel that their lives are 
easier, and feel less inconvenienced by medical treatment 
than did dialysis patients (Johnson, et al., 1982).
In sum, medical status measures are more objective and 
are typically based on an observation by a trained health 
care professional. Also the variables, employment status
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and number of diagnoses, are more objective. Research 
consistently shows that in terms of medical status 
variables, dialysis patients have a poorer QL than other 
ESRD patients.
Psychological Measures. Many studies (e.g., Eiseman, 1981; 
Boulding, 1981; Poznanski et al., 1978) have supported the 
efficacy of examining psychological aspects of QL. 
Psychological measures are subjective measures and are 
almost always based on patient self-report. Evans et al.
(1985) used the Index of Psychological Affect, the Index of 
Overall Life Satisfaction, and the Index of Well-being, all 
developed by Campbell and colleagues (Campbell, et al.,
1976; Campbell, & Converse, 1980). These measures were 
designed to examine the QL of the United States population. 
On three subjective measures (Life Satisfaction, Well-being, 
and Psychological Affect) transplant patients reported a 
higher QL than patients on hemodialysis. Furthermore, home 
dialysis patients also reported better QL than patients 
receiving hemodialysis did. These differences persisted even 
after significant medical/demographic variables (i.e., age, 
disease severity) were controlled statistically.
Poznanski et al. (1978) used an interview to assess 
subjective well-being focusing on life areas such as 
job/school performance, body image, social activities, and 
plans for the future. They found that QL between dialysis 
patients and renal transplant patients was strikingly
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different in almost every area assessed, with renal 
transplant patients having the best adjustment.
Wolcott and Nissenson (1988) used the Simmons Self- 
Esteem Scale, the Profile of Mood States, self-ratings, The 
Multidimensional Health Locus of Control, The Dialysis 
Modality Specific Stresses Scale, the General Treatment 
Stresses Scale, the Global Illness Stresses on Self and 
Others scale, and the Global Adjustment to Illness scales to 
compare home dialysis patients. They concluded that home 
dialysis patients have a modestly better level of 
psychological adaptation than hemodialysis patients.
Johnson, et al (1978) developed their own measures of 
QL based on Campbell's work. Their measures included three 
items that assessed satisfaction with marriage, satisfaction 
with children, and overall life satisfaction, and five items 
assessing negative feelings. Subjective QL was not 
different for the groups. The authors hypothesized that 
denial and accommodation mechanisms may have accounted for 
the lack of differences between the patient groups.
Binik and Devins (1987), in a series of three studies 
compared successful transplant patients, transplant failure 
patients, and dialysis patients, using a variety of 
psychological measures. These were: the McGill Pain 
Questionnaire (Melzack, 1975), Beck Depression Inventory 
(Beck, 1967), Self-esteem Inventory (Coopersmith, Wallston, 
Kaplan, and Maides, 1976), Internal-External Locus of
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Control Scale (Rotter, 1966), Health Locus of Control Scale 
(Wallston, Wallston, Kaplan, and Haldes, 1976), Affect 
Balance Scale (Bradburn, 1969), Profile of Mood states 
(McNair, Forr, & Droppelman, 1971), Hamilton Rating Scale 
(Hamilton, 1967), a self-rating of helplessness (Devins, 
Binik, Hollonby, Barre, and Guttman, 1981), and a checklist 
of somatic symptoms of distress (Devins, Binik, Hutchinson, 
Hollonby, Barre, and Guttman, 198 3). They found no 
significant differences in levels of pain, depression, 
normal mood states, perceived intrusiveness or perceived 
locus of control among hemodialysis as compared to 
transplant or transplant failure patients.
To summarize, research examining psychological status 
variables includes a wide variety of measures. Results 
comparing hemodialysis patients with other ESRD patients 
have been inconsistent, with some studies finding poorer QL 
for hemodialysis patients and others reporting no 
significant differences in QL.
Social Support Measures. Although most studies of QL in 
dialysis patients acknowledge that social support is very 
important (Hartmen & Becker, 1978; Cummings et al., 1982; 
O'Brien, 1980; Kossaris, 1970; Pentecost, Zwerenz, & Manuel, 
1976; steidl, Finkelstein, Wexler, Fergenbaum, Kutson,
Kluger & Quinton, 1980; Sherwood, 1983), it is a variable 
that is frequently omitted. Few standardized measures for 
assessing social support are available, particularly for
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illness populations. For example, Johnson et al. (1982) 
assessed social support by asking hemodialysis and 
transplant patients to list the number of relatives and 
friends they had talked to during the previous month. No 
significant difference was noted between the two groups. 
Binik and Devins (1987) assessed social support via self- 
rating measures of perceived control over eight life areas 
(Devins, et al, 1981), one of which was the family 
dimension. They found no differences in social support based 
on treatment modality or failed transplant.
Wolcott and Nissenson (1988) included current marital 
status, participation in social and leisure activities, 
patient ratings of quality of relationships with other 
dialysis patients, dialysis physicians, and dialysis nurses, 
and patient ratings of satisfaction with five categories of 
social support they had received in the previous three 
months. They compared home dialysis patients with 
hemodialysis patients and reported no differences between 
the groups on marital status, participation in social and 
leisure activities, or satisfaction with social support.
They found that home dialysis patients had more positive 
relationships with other dialysis patients and dialysis 
staff. They concluded that greater independence and autonomy 
for the home dialysis patients may have resulted in better 
relationships.
These studies suggest that researchers have used many
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different measures to assess social support. Social support 
does not appear to differ greatly for ESRD patients 
regardless of their prescribed treatment modality.
In summary, QL is a multidimensional concept not easily 
defined or measured. The previous review of the QL 
literature for dialysis patients has focused on three 
aspects: medical, psychological, and social. A number of 
different measures have been used to assess each of the 
different aspects. It can be concluded that as of now, 
there are no definitive measures for assessing QL for 
dialysis patients. Research suggests that, in general, 
hemodialysis patients have a poorer QL than other ESRD 
patients whose dialysis regimen is less restrictive and 
intrusive.
PROPOSED STUDY
Although hemodialysis removes toxins and metabolic by­
products from the body, it does this less effectively than 
the kidneys (Cummings et al., 1982). To compensate for this 
ineffectiveness, dietary management has been prescribed to 
reduce the amounts of toxins and metabolic by-products 
(e.g., urea, creatinine, sodium, and potassium) that must be 
removed from the body. A prescription for regular 
hemodialysis sessions combined with dietary management 
comprises an intrusive and difficult treatment regimen for 
patients with ESRD. Noncompliance with the regular dialysis 
sessions, will surely result in death. Noncompliance with 
the dietary restrictions may result in relatively mild 
complications ( e.g., nausea, weakness) or at worst, more 
severe complications (e.g., cardiovascular problems, and 
death).
Most patients comply with dialyzing, but are 
notoriously noncompliant with the dietary restrictions, 
despite the consequences (Hartmen & Becker, 1978). 
Considerable effort has been devoted to helping dialysis 
patients improve their compliance, and the literature is 
replete with studies designed to identify factors which 
contribute to noncompliance with the dietary regimen. For 
example, demographic variables are related to compliance, 
but relatively little can be done to alter them (Cummings et 
al., 1982; Mosely, et al., in press). other factors found
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to affect compliance include knowledge of the regimen, 
health beliefs, available social support and regimen 
complexity. Regimen complexity, in particular, is one of 
the most powerful contributors to noncompliance. Most 
professionals believe that compliance with the dialysis 
regimen will prevent or at least abate short-term and long­
term medical complications (Acchiardo, Moore, & Cocherell, 
1984; Barsotti, Giannoni, Morelli, Fozzeri, Vlames, Baldi, & 
Giovannetti, 1984). However, recent research has suggested 
that compliance may have little impact on long-term medical 
complications, such as medical utilization, health status, 
or survival (Bruce, Brantley, Cocke, & McKnight, 1987; 
Ruggiero, 1988). While it may be premature to make changes 
in the prescribed dietary regimen at this stage in the 
research, it is appropriate to continue to examine the 
impact that the regimen has on relevant patient outcome 
variables, one of these being QL. Given the complexity and 
restrictiveness of the regimen, it would appear logical to 
question the impact of the regimen on patients' QL. 
Similarly, this leads to speculation on how restrictive the 
regimen needs to be to prevent short-term complications 
while allowing the highest QL. It is agreed that 
hemodialysis patients suffer a poorer quality of life than 
the general population, and to a large extent, other ESRD 
patients who have had renal transplants or have less 
restrictive dialysis regimens (Hutchinson, 1979; Blagg,
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1985; Evans, Manninen, Marer, Garrison, and Hart, 1985; 
Simmons, Anderson, Kamstra, and Ames, 1985). However as was 
stated earlier, hemodialysis is the treatment of choice for 
most ESRD patients. While little can be done to alter 
medical and demographic variables which effect QL, 
alterations could be made in the dietary regimen if there 
were evidence to support the utility of this. The purpose 
of the present study was to examine the relation between 
dietary regimen (as it is presently being prescribed by 
professionals in renal medicine) and QL in hemodialysis 
patients. It was reasoned that if a positive relation was 
found between compliance and QL then support would be 
provided for treatment efforts to improve compliance. If 
there was a negative relation or no relation found between 
compliance and QL, then research should focus on ways to 
relax the regimen while preventing short-term complications 
and promoting QL. This study also examined the relation 
between significant medical/demographic characteristics in 
predicting QL.
The following questions were addressed.
Question 1. What are the relations between compliance with 
the regimen (as measured by physiological parameters) and 
quality of life?
Question 2. What are the relations between 
demographic/medical variables and quality of life?
Question 3. What parameters of compliance predicted quality
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of life?
Question 4. Did demographic/medical attributes predict 
quality of life?
Question 5. Which patient attributes (physiological 
parameters of compliance, or demographic/medical variables) 
are the better predictors of quality of life?
Predictions based on Question 1. If compliance as measured 
by BUN, IWG, and K is important to quality of life, which 
measures are related to criterion variables reflecting 
quality of life. It was expected that compliance would be 
significantly but modestly correlated with overall quality 
of life. It was predicted that measures of compliance (BUN, 
IWG, SP) would be differentially related to the quality of 
life variables.
Predictions based on Question 2. It was predicted that 
there would be a significant relation between 
medical/demographic variables and quality of 1 ife measures. 
Predictions based on Question 3. Given that measures of 
compliance are important to quality of life, these measures 
were hypothesized to add to prediction of QL. Compliance 
should predict overall quality of life at a modest level. 
Predictions based on Question 4. Given that the patient's 
demographic/medical characteristics are important to his or 
her quality of life, it was hypothesized that these measures 
would predict quality of life at better than chance levels. 
Predictions based on Question 5. Even though both
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compliance variables and demographic/medical variables were 
hypothesized to be important in quality of life, it was 
predicted that demographic/medical variables would be better 
predictors than compliance measures since
medical/demographic characteristics are better predictors of 
other aspects of dialysis (e.g., survival, medical 
utilization).
METHOD
Subjects
A list of 127 eligible patients from the University of 
Alabama Hospital dialysis unit in Birmingham, Alabama was 
obtained based on the following inclusion criteria: a) those 
who had been receiving dialysis treatments for a minimum of 
15 months (prior to November 1, 1987), b) a renal diet with 
recommendations for limiting sodium, potassium, protein, and 
fluid intake, and c) negligible or no remaining urinary 
output. Of the 127 eligible patients, 67 completed the 
study. See Appendix A for the Informed Consent form.
Sixty of the 127 subjects were not included in the 
study for the following reasons: a) refused to participate, 
b) received kidney transplants before they could be 
interviewed, c) died before they could be interviewed, d) 
transferred to another dialysis center, e) insufficient 
biochemical data, or f) were unable to either read the 
questionnaires or comprehend the questionnaires when read to 
them (see Table 1). Subjects were allowed to choose whether 
they wanted to complete the questionnaires by themselves or 
if they wanted to have the questionnaires read to them (due 
to poor eyesight, vascular access in dominant hand, etc.). 
Those who wished to read the questionnaires were required to 
have at least an 8th grade reading level as measured by the 
Wide Range Achievement Test - Revised (Jastak, & Jastak; 
1978). Those who wished to have the questionnaires read to
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them were administered the Comprehension section of the 
WAIS-R (Wechsler, 1981) to assure adequate comprehension 
ability. Subjects were required to obtain a standard score 
of at least 7. The criterion on the Comprehension section 
was lowered to a standard score of 6 for two subjects who 
appeared to understand the questions, had difficulty 
expressing their answers clearly, and had at least a 10th 
grade education. One subject was not screened with either 
instrument, but was high-school educated (see Table 2 for 
scores and education level characteristics).
At the time of the study, the subjects ranged in age 
from 19.6 years to 77.7 years, with a mean age of 50.9.
This sample was 61.2 percent female, 38.8 percent male, 83.6 
percent black, and 14.9 percent white (see Tables 2 and 3). 
Predictor Variables
Certain medical and demographic variables have been 
found to predict health status, medical utilization and 
survival. Therefore, some of them were used as predictor 
variables in this study: 1) age at onset of dialysis (the 
patient's age in years at the time of their first chronic 
dialysis treatment), 2) years on dialysis (total number of 
years from the patient's first chronic dialysis treatment 
until the time period from which the data were collected for 
the proposed study), and 3) the total number of morbid 
conditions coexisting with ESRD (diagnoses included were 
based on review of the literature: diabetes mellitus,
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hypertension, congestive heart failure, chronic obstructive 
pulmonary disease, systemic lupus erythematosus, 1iver 
disease, malignancy, and arteriosclerotic cardiovascular 
disease (See appendix B for medical/demographic form). Age 
of onset of dialysis ranged from 18.1 years to 75.5 years, 
with a mean of 4 5.5. Number of years on dialysis ranged 
from 1.2 years to 22.7 years, with a mean of 5.4 years. The 
number of diagnoses per subject ranged from 0 to 4 with a 
mean of 1.5. (see Tables 2 and 3).
Other predictor variables were the biochemical measures 
blood urea nitrogen (BUN), serum potassium level (K), and 
inter-session weight gain (IWG; see Appendix C for 
compliance criteria). Those measures were chosen because 
they are the most commonly used measures of dietary 
compliance reported in the literature (e.g. Blackburn, 1977; 
Finn et. a l ., 1986; Ferraro et. al., 1986; Cummings et. al., 
1984). Also, they are taken routinely by the dialysis 
staff, and they provide convenient and practical measures 
for research purposes. To ensure reliability and validity, 
a mean was computed on at least 6 repeated measures for BUN 
and K (Ruggiero, 1988). These biochemical measures were 
abstracted from patient medical records for the 15 month 
period prior to the assessment of QL. BUN and K are 
typically measured every two months at the University of 
Alabama at Birmingham dialysis center. Compliance with fluid 
restrictions was assessed by weighing the patient prior to
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each dialysis session and then weighing the patient again 
after dialysis. The difference between the pre and post 
dialysis weights is the intersession weight gain (IWG). IWG 
was abstracted from the medical records for the three months 
prior to the assessment of QL (see Table 4 for the ranges, 
means, and standard deviations of the compliance measures). 
Criterion Variables/Instruments
Four instruments were used to assess quality of life 
(QL). The first measure, the Karnofsky Activity scale (KAS), 
represented the patient's performance of activity (See 
Appendix D). It was completed by the two hemodialysis social 
workers who have consistent contact with the subjects; their 
two ratings were averaged for the statistical analyses. The 
KAS has been found to be both reliable and valid when 
employed by trained health care professionals who are 
familiar with the subjects and who use behaviorally based 
guidelines (Shag, Heinrick, & Ganz, 1984). Specifically, 
Hutchinson et al. (1985) reported that inter-rater 
reliability was poor in the absence of operational criteria 
to define the gradations of the scale. Shag et al. (1984) 
used a series of interview questions to serve as guidelines 
for helping the health care professional determine the 
activity status of the individual. Using them, Shag et al.
(1986) obtained an inter-rater reliability coefficient of 
.89. Those questions were included as part of a brief 
interview in this study (see Appendix E), and an inter-rater
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reliability of .85 was obtained using the Spearman-Brown 
Prophecy formula (see Table 5 for ranges, means, and 
standard deviations of all the QL measures).
The second measure used was the Personal Resource 
Questionnaire (PRQ), a 25-item measure of perceived social 
support (Brandt & Weinert, (1981; see Appendix F).
Evaluation of the instrument supported its internal 
consistency (Chronbach's alpha ranged from .85 to .93 with 3 
different age groups - young adults, middle-aged, and 
elderly). There was also evidence to substantiate content, 
construct, and criterion-related validity. This instrument 
was chosen as the measure of social support because it was 
developed using spouses of a chronic illness population, and 
thus more appropriate than other social support instruments 
for this population.
The third measure used was the Psychological General 
Well-Being Schedule (PGWBS) which provides a brief, but 
broad-ranging indicator of subjective feelings of 
psychological well-being and distress. This scale reflects 
both positive and negative feelings, including anxiety, 
depression, general health, positive well-being, self- 
control, and vitality. Its internal consistency is high (.91 
for males and .95 for females). Test-retest reliability as 
well as validity have been found to be quite adequate 
(McDowell & Newell, 1987; see Appendix G ) .
The fourth, and final measure was the Quality of Life
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Index (QLI) for dialysis patients developed by Ferrans and 
Power (1985). It is a comprehensive measure of subjective 
well-being and quality of life (See Appendix H ) . It is a 
70- item questionnaire that has adequate reliability 
(Chronbach's alpha of .90) and validity.
Procedure
All subjects completed an interview scheduled during 
their routine dialysis treatment which lasted an average of 
45-75 minutes. A consent form was signed by both the 
subject and the experimenter at the beginning of the 
interview. Subjects were told that the objective of the 
study was to examine QL in hemodialysis patients. After the 
consent form was signed, subjects completed either the WRAT- 
R or the Comprehension subtest of the WAIS-R.
Subjects were allowed to complete the questionnaires on 
their own if they were able to read at or above an 8th grade 
level as measured by the WRAT-R. An experimenter was 
available to them during this time in case a problem were to 
arise. If the subject choose to have the questionnaires 
read to him or her, the measures were administered orally by 
the examiner. Demographic and medical information were 
obtained from each subject's medical records. Also, 
biochemical analyses of BUN, SP, and IWG were obtained from 
the medical records.
Staff ratings of activity (KAS) were completed 
independently by two staff social workers within the 1-week
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period the quality of life measures were administered to the 
subject.
RESULTS
Preliminary Analyses
In order to control for the large number of 
correlations calculated, probability was set at pc.01 for 
all analyses in order for the coefficient to be significant. 
A preliminary analysis was done to determine if any 
significant differences existed between the subjects who 
completed the WRAT-R (because they read and answered the 
questionnaires on their own) and the subjects who completed 
the Comprehension section of the WAIS-R (because they had 
the questionnaires read to them and their answers were 
recorded by the interviewer). If the subjects' data were 
significantly different because of their group, error would 
be introduced into the analyses. For example, subjects who 
had the questionnaires read to them may have responded in a 
more socially acceptable manner, making their results 
different from the subjects who completed the measures on 
their own and who may have felt free to respond more 
honestly.
Fifty-one subjects completed the Comprehension subtest, 
and 15 subjects completed the WRAT-R. T-tests yielded no 
significant differences between the two groups on age, age 
beginning dialysis, years on dialysis, number of diagnoses, 
biochemical measures, or the quality of life measures. The 
only significant difference noted between the groups was
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that subjects who completed the WRAT-R were better educated 
(t= - 3.68 (23.9), g < .0007). Given that this was the only 
difference, separate analyses did not appear to be 
warranted.
Another question that warranted investigation before 
the hypotheses were tested was whether or not the quality of 
life (QL) measures (criterion variables) were 
intercorrelated. Correlational analysis revealed 
correlations between scores on the social support measure, 
the Personal Resource Questionnaire (PRQ) and the 
psychological well-being measure, the Psychological General 
Well-being Schedule (PGWBS; r = .33, p<.007), the PRQ and 
the overall QL measure, the Quality of Life Index (QLI; r= 
.44, p < .0002), and the PGWBS and the QLI (r= .51, pc.0001). 
Thus the PRQ, PGWBS, and the QLI were modestly correlated 
with each other. The activity measure, the Karnofsky 
Activity Schedule (KAS) was unrelated to other measures of 
QL (see Table 6).
Also, the intercorrelations between the compliance 
measures were examined. Analysis revealed correlations 
between blood urea nitrogen (BUN) and potassium (K; r= .48, 
pc.0001) and between K and intersession weight gain (IWG; r= 
.34, p< .004). This also indicated a modest correlation 
between the compliance measures (see Table 7).
Pxediction 1
According to Prediction 1, compliance measures should
51
be moderately and significantly correlated with QL measures. 
Furthermore, the compliance measures should be 
differentially correlated with the quality of life measures. 
The results of the analyses indicated that IWG was 
significantly correlated with activity (KAS ; r= . 33 , p < .008; 
see Table 8). No other measures of compliance correlated 
with QL measures (see Table 8). These results are somewhat 
paradoxical since higher levels of activity were associated 
with poorer compliance.
Prediction 2
According to Prediction 2, demographic/medical 
variables are significantly correlated with QL variables.
The results of this analysis revealed significant 
correlations between age and activity (KAS; r= -.59, 
pc.oooi), between age when beginning dialysis and activity 
(KAS; r= -.61, p < .0001), between number of diagnoses and 
activity (KAS; r= -.4 4, p < .007) and between age beginning 
dialysis and social support (PRQ; r=.33, pc.007). Therefore 
Prediction 2 was supported in part (see Table 9), indicating 
that activity is related to certain medical/demographic 
characteristics. Also, social support was related to age 
beginning dialysis.
Prediction 3
According to Prediction 3, measures of compliance 
should add to the prediction of QL. This was tested using a 
stepwise multiple regression procedure. Four multiple
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regressions were done. The three compliance variables (BUN, 
K, and IWG) were entered into the equation to predict social 
support (PRQ). Results again were nonsignificant, R-squared 
(3,61) = .06. Compliance measures were entered into another 
equation to predict psychological well-being (PGWBS). 
Regressions were nonsignificant, R-squared (3,61) = .041. 
Compliance measures were entered into another equation to 
predict overall quality of life (QLI). Results were 
nonsignificant, R-squared (3,61) = .05. Finally, compliance 
measures were entered into the last analysis to predict 
activity (KAS). Results again were nonsignificant, R- 
squared (3,61) = .14. Therefore, Prediction 3 was not 
supported: compliance measures did not add to the prediction 
of QL (see Table 10).
Prediction 4
According to Prediction 4, medical/demographic 
variables significantly should predict QL. This was tested 
using a stepwise multiple regression procedure. Four 
analyses were done, entering the demographic/medical 
information into the equation to predict each of the four QL 
variables. Results of the analysis predicting social 
support (PRQ) were nonsignificant, R-squared (3,61) = .11. 
Results of the analysis predicting psychological well-being 
(PGWBS) were nonsignificant, R-squared (3,61) = .06. Results 
of the analysis predicting overall quality of life (QLI) 
were nonsignificant, R-squared (3,61) = .09. Results of the
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analysis predicting activity (KAS) were significant, R- 
squared (3,61) = .48, p <.0001. Therefore, Prediction 4 was 
supported in part, indicating that in this study, medical 
demographic variables were related to activity (see Table 
11) .
Prediction 5
According to Prediction 5, medical/demographic 
variables combined with compliance variables should 
significantly predict QL. This was tested using a standard 
multiple regression procedure. Four analyses were done, 
entering the demographic/medical and compliance information 
into the equation to predict each of the four QL variables. 
Results of these analyses revealed that the combination of 
medical/demographic and compliance variables significantly 
predicted activity (KAS), R-squared (6,58) = .50, p <.0001. 
Results of the analysis predicting social support (PRQ) were 
nonsignificant, R-squared (6,58) = .18. Results of the 
analysis predicting psychological well-being (PGWBS) were 
nonsignificant, R squared (6,58) = .09. Results of the 
analysis predicting overall quality of life (QLI) were 
nonsignificant, R-squared (6,58) = .14 (see Table 12). Upon 
examination of the beta weights, the medical demographic 
variables add to the prediction with no significant 
contribution made by the compliance variables. Results 
suggest that activity is related to medical/demographic 
variables such as age beginning dialysis and number of
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diagnoses.
Further Analyses
In addition to the above analyses, a canonical 
correlation was performed on the data in hopes that this 
type of analysis may be a more effective technique to 
examine the patterns of interrelationships between the sets 
of variables. This type of analysis seemed particularly 
relevant when one considers that both QL and compliance are 
multidimensional phenomenon. In this analysis, maximal 
linear combinations of the compliance and QL variables were 
formed and correlated. Thus, the compliance measures were 
combined in such a way as to be maximally correlated with 
the QL variables. The canonical analysis of the 
relationship between the compliance variables and the QL 
variables yielded a significant canonical correlation of 
.51, Eigenvalues 35, approx F (12 , 153 . 75) =2 . 43 , £><.006. 
Successive canonical roots were nonsignificant (see Table 
13) .
In order to interpret the canonical correlation, the 
canonical weights and canonical loadings were examined. The 
canonical weights are standardized canonical correlation 
coefficients that indicate how much the variable relates 
independently of the other variables to the extracted 
factor. The canonical loadings are correlation coefficients 
indicating the relation of the canonical variate to the 
extracted factor. Weights and loadings for compliance and QL
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variables are presented in Table 14. Data suggest that the 
compliance variables provide a single factor representing 
compliance. The QL weights and loadings do not provide 
evidence that a single factor contributes to QL. However, 
the measures that appear to be contributing most to the 
extracted factor are activity (KAS) and overall quality of 
life (QLI). The activity measure is positively correlated 
with the extracted compliance factor; the overall quality of 
life measure is negatively correlated with the extracted 
compliance factor. Furthermore, a redundancy analysis, 
which indicates to what extent all the variables in a given 
set are contributing, indicated that the canonical variables 
of both sets accounted for little of the variance and are 
poor predictors of the opposite set of variables (see Table 
15). Therefore, results of the canonical correlation suggest 
that the extracted compliance factor is weakly, although 
positively related to activity (KAS). Accordingly, poor 
compliance is associated with better activity levels. Also, 
the extracted QL factor is weakly, although negatively 
related to the compliance factor. This indicates that poor 
compliance is associated with poor subjective QL.
DISCUSSION
The purpose of this study was to determine the 
association between compliance with the dietary regimen and 
quality of life (QL) in patients receiving chronic in-center 
hemodialysis. This was done by examining the relation 
between three physiological parameters of dietary compliance 
(blood urea nitrogen, potassium, and intersession weight 
gain) and four measures of QL (The Karnofsky Activity Scale, 
Psychological General Well-Being Schedule, Personal Resource 
Questionnaire, and the Quality of Life Index). Furthermore, 
the relation between medical/demographic characteristics 
(age, years on dialysis, age beginning dialysis, and number 
of diagnoses) and QL was examined. In general, the results 
of this investigation failed to demonstrate a strong 
relation between compliance with the dietary regimen and QL. 
Medical/demographic characteristics were modestly associated 
with QL.
The first hypothesis of this study proposed that 
compliance would be associated with QL. In general, little 
relation was found between them. Traditionally, compliance 
with the diet has been a very important part of the dialysis 
regimen. For instance, professionals in renal medicine have 
proposed that compliance with the dietary regimen would 
decrease morbidity, mortality, hospitalizations, and medical 
utilization. However, recent research has found that 
compliance is not related to these relevant outcome
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variables (Bruce et al., 1987; Ruggiero, 1988). Another 
relevant outcome variable, QL, also does not appear to be 
related to compliance. The present findings call into 
question the emphasis that traditionally has been placed on 
compliance. If compliance is not related to relevant 
outcome variables, then recommendations about revising and 
possibly loosening the restrictions of the dietary regimen 
may be in order. However, before specific treatment 
recommendations could be made, replication of this study, as 
well as more systematic investigation, would be warranted.
The second hypothesis of this study was that 
medical/demographic characteristics would be associated with 
QL. In general, a relation between medical/demographic 
characteristics and quality of life was found.
Specifically, older patients who were older when they began 
dialysis, and who were rated sicker were less active. Also, 
the older the patients when they began dialysis, the better 
they rated their social support. The association between 
age, age beginning dialysis, number of diagnoses and 
activity makes intuitive sense. The older and sicker the 
patients, the less likely they are to carry on activities 
associated with younger people in good health, such as 
having a job or participating in a wide variety of 
activities.
The implication that those who began dialysis at a 
later age are more satisfied with their social support is
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more difficult to explain. One would wonder if those who 
started dialysis at a younger age lost their social support 
as a result of their illness. Perhaps patients beginning 
dialysis later in life, during a time when family and 
friends expect their loved ones to develop health problems, 
are better incorporated into the social network as a result 
of this expectation. Younger people may not be expected to 
develop chronic illnesses that require such intensive care 
and support. This, however, is speculative and would 
warrant further investigation.
Although little can be done to improve 
medical/demographic variables, there could be benefits 
associated with knowing that these variables may be related 
to quality of life. Health care professionals could 
identify, in advance, those patients who are likely to 
suffer from poorer quality of life (i.e., a "high risk" 
profile). Once identified, these patients may benefit from 
a referral for additional rehabilitation aimed at improving 
their QL. Furthermore, the results of this study confirm 
the need to provide conscientious and swift medical 
assessment and treatment for other medical problems 
associated with chronic renal failure. Also, recent 
research has indicated that the relationships between 
dialysis staff and patients are important (e.g., Steidl et 
al., 1980; Cummings et al., 1981). For patients within the 
high risk group, additional staff support and involvement
59
may help improve QL.
Another hypothesis of this study was that compliance 
would predict QL. The results indicated that compliance 
does not predict quality of life, further supporting the 
results of the correlational analysis. Therefore, knowing 
that patients are compliant with their diet does not 
necessarily assure that they will experience a better 
quality of life. As has been mentioned previously, this 
finding has been parallelled in studies investigating other 
relevant medical outcomes. One would wonder why compliance 
does not predict quality of life. Probably, there are no 
simple answers to this question. It may be that the dietary 
regimen really is not as important as has been thought. 
Before this statement can be made with any assurance, 
replication of studies should be done as well as more 
specific research regarding the role of compliance for 
dialysis patients. An example of this would be to study 
groups receiving different dietary regimens, i.e., a control 
group that receives the regimen as it is presently being 
prescribed, another group receiving a slightly less 
restrictive regimen, and perhaps another group receiving a 
very strict regimen. Another possibility for the lack of 
prediction may be due to the difficulties and possible error 
in the measurement of the constructs of compliance and QL. 
These issues will be discussed in a later section.
This study also hypothesized that medical/demographic
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characteristics would predict QL. They predicted one aspect 
of QL - activity. It seems sensible that
medical/demographic characteristics such as age and number 
of diagnoses would predict activity levels. It is expected 
that individuals who are older or sicker may be less active. 
In contrast, other, more subjective aspects of QL, such as 
social support, psychological well-being, or overall quality 
of life, were not predicted by medical/demographic 
characteristics. This finding is consistent with past 
research (e.g., Evans et al.,1985; Johnson et al.,1982) that 
found little relation between medical/demographic 
characteristics and subjective measures of quality of life. 
For example, hemodialysis patients in both studies had 
poorer medical status than transplant patients, yet reported 
subjective quality of life to be very similar to the 
transplant patients and to the general population. It is not 
clear how dialysis patients can protect themselves 
psychologically from the losses associated with their 
illness and treatment, but it seems that human beings have 
the ability to adapt to unfortunate circumstances and to 
"make the best" of it. Future research focusing on how 
individuals interpret and evaluate this type of negative 
experience may be useful in facilitating adjustment to 
chronic illnesses, like end stage renal disease.
This study also attempted to answer the question of 
which variables would be better predictors of QL: compliance
61
variables or medical/demographic characteristics.
Compliance added little to prediction, and as hypothesized, 
medical demographic variables provided the best prediction 
of QL. These results were not surprising given the results 
of the separate analyses.
A canonical correlation was done since this analysis is 
thought to be particularly helpful in studying 
multidimensional concepts such as QL and compliance. The 
result of that analysis addressing the relation between the 
dietary variables and QL only weakly supported the 
association between compliance and QL. The extracted 
compliance variate modestly predicted activity, revealing 
that poorer compliance was associated with better ratings of 
activity, a contradictory finding. The compliance variate 
was not able to predict any other aspects of QL. The 
extracted QL variate indicated that lower levels of overall 
QL were associated with poorer compliance.
The results of the canonical correlation are difficult 
to explain. A relation between compliance and quality of 
life is suggested, specifically poor compliance is 
associated with poor subjective QL. However, this same poor 
compliance is associated with higher activity levels, as 
measured by health care professionals. One possible 
explanation for this is that dialysis patients who were 
attempting to be as active as they could and lead as normal 
a life as possible were rated more functional. Their
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continued efforts to lead a normal life were done at the 
expense of their diet and their subjective QL. Patients who 
were struggling to continue working or to take care of their 
homes and families may have perceived that that they had 
fewer resources to care for themselves and may have felt 
less satisfied with their lives. A variant of this 
explanation is that those who were attempting to be more 
active and functional may have been denying the reality of 
their illness. As a result of this denial, they may also 
have been less compliant. These explanations are quite 
speculative and would require further research. However, 
each of the above explanations have treatment implications. 
For example, if patients were trying to function at previous 
levels of ability or denying their illness, treatment should 
help patients adjust their expectations to levels consistent 
with their current functional deficits. Osberg, McGinnis, 
De Jong, & Seward (1987), indicated that this is a primary 
task for patients experiencing life changes as a result of 
chronic illness.
One finding of this study that warrants further 
explanation is the low correlations among the QL measures: 
The Quality of Life Index (QLI), The Personal Resources 
Questionnaire (PRQ), The Psychological General Well-being 
Schedule (PGWBS), and the Karnofsky Activity Scale (KAS).
The first three measures are subjective measures and 
represent overall quality of life, satisfaction with social
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support, and psychological well-being. These three measures 
were modestly correlated. However, the KAS, a medical 
status variable, was not correlated with the other measures 
of QL. Although some may think it is appropriate to discard 
this measure as a QL variable due to its poor association 
with other measures of QL, it remains one of the more 
objective measures traditionally used in research. 
Discrepancies between objective and subjective measures are 
not uncommon (e.g., Slevin et al*, 1988).
The lack of correlation between the KAS and other 
measures of QL may have been due to the KAS measuring a 
different aspect of QL. To some extent, all of the 
variables used in this study (social support, psychological 
well-being, and overall quality of life) appeared to measure 
different aspects of QL. This finding is consistent with 
Wolcott et al.'s (1988) investigation of quality of life 
that medical, psychological, and social support variables 
were only weakly correlated.
The low inter-correlations among the quality of life 
variables point to an important question not directly 
addressed by this study. What constitutes quality of life? 
As reviewed in another section of this paper, quality of 
life is a complex phenomenon which defies easy definition or 
measurement. Little agreement has been reached among 
researchers or clinicians about what constitutes it or how 
it is measured. Quality of life is a multidimensional
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phenomenon. Adequately determining what dimensions comprise 
QL and designing appropriate measures is a task for future 
research. Although conscientious attempts were made to 
assess quality of life in this study, one problem may have 
been that the measures did not sufficiently represent the 
construct of quality of life for these subjects. Quality of 
life is an important topic, and perhaps more effort should 
be placed in defining and measuring it rather than designing 
studies using inadequate measures.
Another finding that warrants explanation is the 
significant and modest correlations among the compliance 
variables. Other studies (e.g., Bruce, et a l ., 1987) have 
suggested that compliance with one aspect of the regimen is 
correlated with compliance with other aspects of the 
regimen. This finding was supported in this study. Measures 
of BUN were significantly correlated with K; IWG was 
significantly correlated with K. Although IWG was not 
significantly correlated with BUN, the relation was 
suggestive. The canonical analysis provided further evidence 
that the compliance variables were correlated and together 
formed a factor that measured compliance.
A concern in interpreting the results of this study was 
whether or not compliance was adequately measured. As 
discussed earlier, compliance is a difficult construct to 
define and measure. Also, defining and measuring compliance 
will depend upon the type of illness the individual has.
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The measures included in this study - BUN, K and IWG, are 
the most frequently used ones in dialysis research. Previous 
research (e.g., Ruggiero, 1988) has demonstrated the 
appropriateness of using multiple data points to obtain a 
more representative sample. Also, the measures when 
statistically combined provided a reasonable factor 
representing compliance. Without straying too far from the 
data, it does appear that compliance as it is defined for 
dialysis patients was measured adequately. Whether or not 
the construct of compliance was sufficiently represented is 
uncertain. Limitations in measurement techniques continue 
to be a problem in compliance research that should be 
addressed in future research.
The methodology of the current study may suffer from 
certain shortcomings. Specifically, sampling and selection 
criteria were done in an effort to get as many of the 
eligible patients to participate as possible. Of the 
original 127, only 67 participated in the study. This 
indicates that this sample may not be highly representative 
of the dialysis patients at large. Furthermore, this study 
was conducted in a dialysis center in a southern city in 
which the dietary habits, racial, ethnic, and cultural 
subsamples may not be representative of a national sample. 
This makes the generalizability of this study more 
restricted, and conservative interpretation warranted.
In summary, the regimen may have little impact on QL.
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Other studies have found that compliance has little impact 
on other relevant medical goals, making the necessity for 
the restrictive regimen questionable. Future research may 
emphasize loosening of the dietary restrictions while 
educating patients about the aspects of their diet that can 
cause acute complications and uncomfortable dialysis 
sessions. Medical/demographic variables such as age, age 
beginning dialysis, and number of diagnoses predict 
activity, one aspect of QL. While little can be done to 
alter medical/demographic variables, knowledge of their 
impact may help provide a high risk profile of patients who 
may experience poor health, increased morbidity and 
mortality, and poor quality of life. However, the current 
findings should be replicated using a broader sample and 
giving further consideration to measuring the construct of 
quality of life.
REFERENCES
Abram, H.S., Moore, G.L., & Westervelt, F.B. (1971). 
Suicidal behavior in chronic dialysis patients. 
American Journal of Psychiatry. 127. 1119-1204. 
Acchiardo, S., Moore, L.W., & Cocherell, S. (1984). Does 
low-protein diet halt the progression of renal 
insufficiency? Proceedings of the IX International 
Congress on Nephrology.3Q7A.
Alfrey, A.C. (1980). Chronic renal failure:
Manifestations and pathogenesis. In R.W. Schrier 
(Ed.), Renal and electrolyte disorders (pp. 409-441), 
Boston: Little, Brown and Company.
Andrews, F.M., & Withey, S.B. (1976). Social indicators of 
well-being in America: The development and measurement 
of perceptual indicators, London; Plenum Publishers. 
Barsotti, G . , Giannoni, A . , Morelli, E., Lazzeri, M.
Vlamis, I., Baldi, R., & Giovannetti, S. (1984).
The decline of renal function slowed by very low 
phosphorus intake in chronic renal patients following 
a low nitrogen diet. Clinical Nephrology. 21. 54-59. 
Beck, A .T . (1967). Depression: Clinical. Experimental.
and Theoretical Aspects. New York: Harper and Row. 
Becker, M.H., & Rosenstock, I.M. (1984). Compliance with 
medical advice. In A. Steptoe & A. Mathews (Eds.) 
Health care and human behavior (pp. 175-208).
New York: Academic Press.
67
Binik, Y.M. & Devins, G.M. (1987). Transplant failure does 
not compromise quality of life in end stage renal 
disease. International Journal of Psychiatry in 
Medicine. 15, 281-292.
Blackburn, S. (1977). Dietary compliance of chronic 
hemodialysis patients. Journal of the American 
Dietetic Association. 10. 449-460.
Blagg, C.R. (1985). Treatment of end-stage renal
disease by dialysis. Transplantation. XVII, 1497-1499
Boulding, K.E. (1980). Science and our common heritage. 
Science. 207. 831-836.
Bradburn, N.M. (1969). The Structure of Psychological 
Well-being. Chicago: Aldine.
Bradley, J.R., Evans, D.B., and Caine, R.T. (1987). Long­
term survival in hemodialysis patients. The Lancet. 
February 7, 295-296.
Brandt, P.A. & Weinart, C. (1981) The PRQ - A
social support measure. Nursing Research. 30. 277-280
Brennan, A.F., Davis, M.H., Buchholz, D.J., Kuhn, W.F., 
Gray, L.A. (1987). Predictors of quality of life 
following cardiac transplantation. Psvchosomatics.
28. 566-571.
Bruce, B.K., Brantley, p.J., Cocke, T.C., & McKnight, 
g .t . (1988). The assessment of health status in 
hemodialysis patients. Manuscript submittedfor 
publication.
Burke, J .F ., Francos, G.C., Moore, C.C., Cho, S.Y.,
& Lasker, N. (1978). Accelerated atherosclerosis in 
chronic dialysis patients -another look. Nephron.
21. 181-185.
Burton, B.J. (1974). Current concepts of nutrition and diet 
in diseases of the kidney. Journal of the American 
Dietetic Association. 65. 623-626.
Burton, H.J., Kline, S.A., Lindsay, R.M., Heidenheim, A.P. 
(1986). The relationship of depression to survival in 
chronic renal failure. Psychosomatic Medicine. 48. 2 61- 
269.
Butt, K. M. H. (1983) Angioaccess. In w. Drukker, F.M.
Parsons, & J * F. Maher (Eds.), Replacement of renal 
function bv dialysis (pp. 171-185), Boston: Martinus 
Nijhoff Publishers.
Cameron, J.S., Russell, A.M.E., & Sales, D.N.T. (1976) 
Nephrology for Nurses. Flushing, New York:
Oxford Press.
Campbell, A. Converse, P.E. & Rodgers, W.L. (1976).
The quality of American life: Perceptions, 
evaluations and satisfactions. New York: Russell 
Sage Foundation.
Campbell, A., and Converse, P.E. (1980). The quality
of American life, 1978. Ann Arbor, Michigan: Inter-
University Consortium for political and social 
research.
Carlson, D.M., Johnson, W.J., Kjellstrand, C.M. (1987). 
Functional status of patients with end-stage 
renal disease. Mavo Clinic Proceedings. 62, 338-344. 
Coburn, J.W., & Llach, F. (1983). Renal
osteodystrophy and maintenance dialysis. In W.
Drukker, F.M. Parsons, & J.F. Maher (Eds.), Replacement 
of renal function (pp. 679-711), Boston:
Martinus Nijhoff Publishers.
Comty, C.M., & Shapiro, F.L. (1983). Cardiac complications 
of regular dialysis therapy. In W. Drukker, F.W. 
Parsons, & J.F. Maherf (Eds.), Replacement of renal 
function (pp. 595-610), Boston: Martinus Nijhoff 
Publishers.
Coopersmith, S. (1967). The antecedents of self­
esteem. San Francisco: Freeman.
Cummings, K.M., Becker, M.H., Kirscht, J.P., & Levin, N.w.
(1981). Intervention strategies to improve compliance 
with medical regimens by ambulatory hemodialysis 
patients. Journal of Behavioral Medicine. 4, 111-127.
Cummings, K.M., Becker, M.H., Kirscht, J.P., & Levin, N.W.
(1982). Psychosocial factors affecting adherence 
to medical regimens in a group of hemodialysis 
patients. Medical Care. 20. 567-580.
71
Cummings, K.M., Kirscht, J.P., Becker, M.H., & Levin,
N.W. (1984). Construct validity comparisons of three 
methods for measuring patient compliance. Health 
Services Research. 11, 103-116.
DeHaes, J .C.J.M., & Knippenberg, F.C.E. (1985). The
quality of life of cancer patients: A review of the 
literature. Social Science and Medicine. 10, 809-817. 
Devins, G.M., Binik, T.H., Hollonby, D.J., Barre, P.E.
& Guttman, R.D. (1981). Helplessness and depression in 
end-stage renal disease. Journal of Abnormal 
Psychology. 90, 531-545.
Devins, G.M., Binik, T.M., Hutchinson, T.A., Hollonby, D.J. 
Barre, P.E., and Guttman, R.D. (1983). The emotional 
impact of end-stage renal disease: Importance of 
patients' perception of intrusiveness and control. 
Internaltional Journal of Psychiatry in Medicine.
13, 327-343.
Dolgin, M.J., Katz, E.R., Doctors, S.R., & Siegel, S.E.
(1986). Caregivers' perceptions of medical compliance. 
Journal of Adolescent Health Care. 7, 22-27.
Eisman, B. (1981). The second dimension. Archives of 
Surgery. 116. 11-13.
Eraker, S.A., Kirscht, J.P., & Becker, M.H. (1984).
Understanding and improving patient compliance. Annals 
of Internal Medicine.100. 258-268.
Eschbach, J.w. (1983). Hematologic problems of dialysis
patients. In W. Drukker, F.M. Parsons, & J .F.
Maher (Eds.), Replacement of renal function (pp. 630- 
645), Boston: Martinus Nijhoff Publishers.
Evans, R.W., Manninnen, D.L., Garrison, L.P., Hart, G.,
Blagg, C.R., Gutman, R.A., Hull, A.R., & Lowrie, E.G. 
(1985). The quality of life of patients with ESRD. The 
New England Journal of Medicine. 312. 553-559.
Evans, R.W., Manninen, D.L., Maier, A . , Garrison, L.P.,
& Hart, L.G. (1985). The quality of life of kidney and 
heart transplant recipients. Transplantation 
Proceedings. XVII. 1579-1582.
Ferrans, C.E., & Powers, M.J. (1985). Quality of
life index: Development and psychometric properties. 
AKS, £, 15-24.
Ferraro, K.E., Dixon, R.D., & Kinlaw, B. (1986). Measuring 
compliance among in-center hemodialysis patients. 
Dialysis & Transplantation. 15. 226-2 36.
Finn, P.E., & Alcorn, J.D. (1986). Noncompliance to
hemodialysis dietary regimens: Literature review 
and treatment recommendations. Rehabilitation 
Psychology. 21, 67-78.
Fisher, A.B. (1983). Washington reins in the
dialysis business. Fortune. July 25, 66-69.
Flanagan, J.C. (1982). Measurement of Quality of life: 
Current state of the art. Archives of Physical 
Medicine and Rehabilitation. £2, 56-59.
Freeman, R.B. (1986). Living with End-Stage Renal Disease: 
Prolonging life or extending the dying process. In 
M.A. Hardy (Ed.), Positive approaches to living with 
end-stage renal disease (pp.83-94), New York: Praeger
Ganz, P.A., Haskell, C.M., Figlin, R.A., LaSota, N . ,
Siaus, J. (1988). Estimating the quality of life 
in a clinical trial of patients with metastatic lung 
cancer using the Karnofsky Performance Status and 
the Functional Living Index. Cancer. 61. 849-856.
Ginn, H-E., & Teschen, P.E. (1983). The quality of life
of the chronic dialysis patient. In W. Drukker, F.M. 
Parsons, & J.F. Maher, (Eds.), Replacement of renal 
function (pp. 837-843). Boston: Martinus Nijhoff 
Publishers.
Greenwald, H.P. (1987). The specificity of quality of
life measures among the seriously ill. Medical Care. 
25. 642-651.
Gurin, G . , Verhoff, J., Feld, S. (1960). Americans view 
their health. New York: Basic Books.
Hamilton, M. (1967). Development of a rating scale for 
primary depressive illness. British Journal of 
Social and Clinical Psychology. 6, 278-279.
Hartman, P.E., & Becker, M.H. (1978). Noncompliance with
prescribed regimen among chronic hemodialysis patients. 
Dialysis & Transplantation. 7, 978-985.
Haynes, R.B. (1982). Improving patient compliance: An 
empirical view. In R.B. Stuart (Ed.), Adherence. 
compliance and genralization in behavioral medicine 
(pp. 56-78). New York: Brunner/Mazel Publisher.
Hirschman, G.H., Wolfson, M . , Mosemann, J.E., Clark, C.B., 
Dante, M.L. & Wineman, R.J. (1981). Complications 
of dialysis. Clinical Nephrology. 15, 66-74.
Hollandsworth, J.G. (1988). Evaluating the impact of
medical treatment on the quality of life: A 5-year 
update. Social Science & Medicine. 26, 425-434.
Hutchinson, T.A., Boyd, N.F., Feinstein, A .R ., Gonda,
A. Hollomby, D., & Rowat, B. (1972). Scientific
Problems in clinical scales, as demonstrated in the 
Karnofsky Index of Performance Status. Journal of 
Chronic Disease. 32. 661-666.
Jastak, J.F., & Jastak, S. (1978). The Wide Range
Achievement Test (rev. ed.). Wilmington, Delaware: 
Jastak Associates.
Jennekens, F.G., & Jennekins-Schinkel, A. (1983).
Neurological aspects of dialysis patients. In 
W.Drukker, F.M. Parsons, & J.F. Maher (Eds.), 
Replacement of renal function (pp. 724-741), Boston: 
Martinus Nijhoff Publishers.
Johnson, J.P., McCauley, C.R., & Copely, J.B. (19B2).
The quality of life of hemodialysis and transplant 
patients. Kidney International. 22., 286-291.
Kaplan, G.A., & Camacho, T. (1983). Perceived health 
and mortality: A nine year follow-up of the human 
population cohort. American Journal of Epidemiology.
117. 292-304.
Kaplan De-Nour, A., & Czaczkes, J.W., (1979). Bias in
assessment of patients on chronic dialysis. Journal of 
Psychosomatic Research. 18. 217-224.
Kaplan De-Nour, A., & Czaczkes, J.W. (1972). Personality 
factors in chronic hemodialysis patients causing 
noncompliance with the medical regimen.
Psychosomatic Medicine. 34. 333-344.
Karnofsky, D.A., and Burchenal, J.H. (1949). The clinical 
evaluation of chemotherapeutic agents in cancer. In 
C.M. Macleod (ed.), Evaluation of chemotherapeutic 
agents. (pp. 191-205), New York:Columbia University 
Press.
Keane, W.F., & Raij, L.R. (1983). Host defenses and
infectious complications in maintenance hemodialysis 
patients.In W. Drukker, F.M. Parsons, & J.F. Maher 
(Eds.), Replacement of renal function (pp. 646-658), 
Boston: Martinus Nijhoff Publishers.
Kluthe, R.K.A. (1983). Nutrition in dialysis patients. In 
W. Drukker, F.H. Parsons, & J.F. Haher (Eds.), 
Replacement of renal function (pp. 569-574), Boston: 
Martinus Nijhoff Publishers.
Knochel, J.P., & Seldin, D.w. (1981). The pathophysiology 
of uremia. In B.M. Bronner, & F.C. Rector (Eds.),
The kidnev (pp.2137-2183), Philadelphia: W.B. Saunders 
Company.
Kokko, J. (1985). Chronic renal failure. In J.B.
Wyngaarden, & L.H. Smith (Eds.), Cecil textbook of 
medicine (pp. 501-520), Philadelphia: W.B. Saunders 
Company.
Kossoris, P. (1970). Family therapy as an adjunct to
hemodialysis and transplantation. American Journal 
of Nursing. 70. 1730-1733.
Kutner, N.G., Fair, P.L., & Kutner, M.H. (1985). Assessing 
depression and anxiety in chronic dialysis patients. 
Journal of Psychosomatic Research. 29. 23-31.
Longo, E. D. (1981). Psychosocial responses to chronic 
hemodialysis. Physician Assistant & Health 
Practitioner. 26-30.
Luke, R.G. (1985). Treatment of irreversible renal failure.
In J.B. Wyngaarden, & L.H. Smith (Eds.), Cecil textbook 
of medicine (pp.559-563), Philadelphia: W.B. Saunders 
Company.
Maker, E.R., & Curtis, J.R. (1987). Mortality and
morbidity of long-term hemodialysis. The Lancet. 
February 21, 4 52-4 53.
Man, N.K., & Jungers, P. (1979). Chronic hemodialysis:
Basic principles. In J.Hamburger, J. Crosnier, J. 
Grunfeld (Eds.), Nephrology (pp. 1199-1229). New York: 
John Wiley & Sons.
McDowell, I., & Newell, C. (1987). Measuring health: A
guide to rating scales and questionnaires. New York: 
Oxford University Press.
Masur, F.T. (1981). Adherence to health care regimens. In
C.K. Prokop & L.A. Bradley (Eds.), Medical psychology: 
Contributions to behavioral medicine (pp.441-470), New 
York: Academic Press.
McNair, D.M., Forr, M . , & Droppelman, L.F. (1971).
EITS manuel for the Profile of Mood States. San Diego: 
Educational and Industrial Testing Service.
Melazck, R. (1975). The McGill Pain Questionnaire: Major
properties and scoring methods, Pain. 1, 277-299.
Mosley, T.H., Brantley, P.J., Jones, G.N., & Cocke, T.B.
(in press). Predicting compliance of in-center 
hemodialysis patients to vascular access cleansing. 
Journal of Compliance in Health Care.
Nehemkis, A.M.,& Gerber, K.E. (1986) Compliance and the
quality of survival. In K.E. Gerber, & A.M. Nehemkis 
(Eds.), Compliance: The dilemma of the chronically ill 
(pp. 73-97). New York: Springer Publishing Company.
Norton, J.c. (1982). Introduction to medical psychology.
New York: The Free Press.
O'Brien, M.B. (1980). Hemodialysis regimen compliance and 
social environment. Nursing Research. 29. 250-255.
Osberg, J.S., McGinnis, G.E., DeJong, G . , & Seward, M.L.
(1987). Life satisfaction and quality of life among 
disables elderly adults. Journal of Gerontology. 42. 
228-230.
Palakoff, S. (1983). Dialysis associated with hepatitis. In 
W. Drukker, F.M. Parsons, & J.F. Maher (Eds.), 
Replacement of renal function (pp. 659-678),
Boston: Martinus Nijhoff Publishers.
Palmore, E., & Luikart, C. (1972). Health and social
factors related to life satisfaction. Journal of Health 
and Social Behavior.13. 68-80.
Park, L.C. & Lipman, R.S. (1964). A comparison of patient 
dosage deviation reports with pill counts. 
Psvchopharmacoloaia. 6, 299-302.
Pentecost, R.L., Zwerenz, B., & Manuel, J. (1976)
Intrafamily identity and home dialysis success.
Nephron. 1 2 , 88-91.
Poznanski, E.O., Miller, E., Salquero, C., & Kelsh, R.C.
(1978). Quality of life for long-term survivors of End- 
Stage Renal Disease. JAMA. 239. 2343-2347.
Raczynski, J.M., & Oberman, A. (1989). Quality of life
among cardiovascular surgery patients. In Spilker, B. 
(Ed.), Quality of life assessment in clinical 
studies. In press.
Reiman, A.S. (1982). Race and end stage renal disease.
The New England Journal of Medicine. 306. 1290-1291.
Rodriguez, D.J., & Hunter, V.M. (1981). Nutritional 
intervention in the treatment of chronic renal 
failure. Nursing Clinics of North America. 16.
573-585.
Rosensky, S.J., and Eggers, P.w. (1987). Trends in the us 
end-stage Renal Disease population: 1973-1983.
American Journal of Kidney Diseases. 9, 91-97.
Rostand, S.G., Kirk, K.A., Rutsky, E.A., & Pate, B.A.
(1982). Racial differences in the incidence of 
treatment for End-Stage Renal Disease. The New England 
Journal of Medicine. 306. 1276-1277.
Rostand, S.G., & Rutsky, E.A. (1984). Cardiac disease in
dialysis patients. In A.R. Nissenson, R.N. Fine, & D.E. 
Gentile (Eds.), Clinical dialysis (pp. 395-437), 
Norfolk, Connecticut: Appleton-Century-Crofts.
Roth, H.P., Caron, H.S., & Hsi, B.P. (1970) Measuring
intake of prescribed medication. Clinical Pharmacology 
and Therapeutics. 11. 228-237.
Rotter, J.B. (1966). Generalized expectancies for internal
versus external control of reinforcement. Psychological 
Monographs. ££, 121-128.
Ruggiero, L. (1987). Effects of dietary compliance on 
survival in hemodialysis patients. Unpublished 
doctoral dissertation, Louisiana State University,
Baton Rouge, Louisiana.
Salmons, P.H. (1980) Psychosocial aspects of chronic renal 
failure. British Journal of Hospital Medicine. 16. 
29-34.
Schrier, R.W., & Conger, J.D. (1980). Acute renal failure.
In R.W. Schrier (Ed), Renal and electrolyte disorders 
(pp.375-408), Boston:Little, Brown and Company.
Shag, C.C., Heinrich, R.L., & Ganz, P.A. (1984).
Karnofsky Performance Status: Reliability, validity, 
and guidelines. Journal of Clinical Oncology.
Z, 187-193.
Sherwood, R.J. (1983). Compliance behavior of hemodialysis 
patients and the role of the family. Family Systems 
Medicine. 1, 60-72.
Simmons, R.G., Anderson, C.R., Kamstra, L.K., &
Ames, N.G. (1985). Quality of life and alternate 
end-stage renal disease therapies. Transplantation 
Proceedings. XVII. 1577-1578.
Slevin, M.L., Plant, H., Lynch, D., Drinkwater, J.,
Gregory, W.M. (1988). Who should measure quality of 
life, the doctor or the patient. British Journal of 
Cancer, £7, 109-112.
Steidl, J.H., Finkelstein, F.O., Wexler, J.P., Fergenbaum,
H., Kitsen, J., Kliger, A.S., & Quinlan, P.M. (1980). 
Medical condition, adherence to treatment regimens, 
and family functioning. Archives of General Psychiatry 
37. 1025-1027.
Stein, J.H. (1985). Acute renal failure. In J.B. Wyngaarden 
& L.H. Smith (Eds.), Cecil textbook of medicine 
(pp. 494-501), Philadelphia: W.B. Saunders Company.
Stewart, R.S.(1985). Psychiatric issues in renal dialysis
transplantation. Hospital and Community Psychiatry. 34 
623-628.
Stone, G .C. (1979). Patient compliance and the role of the 
expert. Journal of Social Issues. 35, 34-59.
Streltzer, J., & Hassell, L.H. (1988). Noncompliant
hemodialysis patients: A biopsychosocial approach. 
General Hospital Psychiatry. 1£, 255-259.
Turk, D.C., Salovey, P., & Litt, M.D. (1986). Adherence:
A cognitive-behavioral perspective. In K.E. Gerber, & 
A.M. Nehemkis (Eds.), Compliance: The dilemma of the 
chronically ill (pp. 44-72), New York: New York: 
Springer Publishing Company.
Wallston, B.S., Wallston, K.A., Kaplan, G.D., and Maides, 
S.A. (1976). Development and validation of the 
Health Locus of Control (HLC) Scale. Journal of 
Consulting and Clinical Psychology. 44. 580-585.
Wauters, J.P., Hunziker, A . , & Brunner, H.R. (1983).
Regionalized self-care hemodialysis. JAMA. 250. 59-62
Wechsler, D. (1981). Wechsler adult intelligence scale-
revised . Cleveland, Ohio: Harcourt Brace Jovanovich, 
Publishers.
White, R.P., & Rubin, A.L. (1983). Blood pressure control 
in chronic dialysis patients. In W. Drukker, F.M. 
Parsons, & J.F. Maher (Eds.), Replacement of renal 
function (pp. 575-587). Boston: Martinus Nijhoff 
Publishers.
Wolcott, D.L., Nissenson, A.R., & Lansverk, J. (1988).
Quality of life in chronic dialysis patients. General 
Hospital Psychiatry. 10. 267-277.
Wolcott, D.L., & Nissenson, A.R. (1988). Quality of life 
in chronic dialysis patients: A critical comparison 
of continuous ambulatory peritoneal dialysis and 
hemodialysis. American Journal of Kidney Disease.
X I . 402-412.
Wright, L.F. (1981). Maintenance hemodialysis. Boston: G. 
Hall Medical Publishers.
Table 1
Frequency of Subjects Excluded From the Study (N=60)
REASONS FREQUENCY
Refused 16
Transplanted 2
Died 4
Transferred 1
Incomplete Data 4
Comprehension Deficits 33
84
Table 2
Sample Characteristics
Characteristics N Mean SD Ranae
Age 67 50.9 11.9 19.6-77.4
Years on Dialysis 67 5.4 4.0 1.2-22.7
Age began Dialysis 67 5.5 12 . 3 18.1-75.5
# Diagnoses 67 1. 5 0 . 9 0-4
Comprehension 51 7.9 1.6 6-14
WRAT-R 15 95.7 13.6 71-125
Education 67 11. 5 3 . 3 3-20
85
Table 3
Further Demographic Characteristics
Characteristics N Percent
Sex
Male 26 38 . 8
Female 41 61. 2
Race
Black 56 83 . 6
White 11 16.4
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Table 4
Means, Standard Deviations, Ranges of Compliance Measures
Characteristic N Mean SD Ranqe
BUN 67 73.67mg/ml 15.8 37.6-112.0
K 67 5.OmEq . 62 3.7-6.3
IWG 67 2 . 8kg .89 1.6-5.1
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Tabla 5
Means, Standard Deviations, Ranges of Quality of
Life Measures
QL Measures N Mean SD Ranae
KAS 66 75 . 5 10.9 50-100
PRQ 66 146 22.9 72-173
PGWBS 67 78 - 9 18 . 5 34-110
QLI 67 23 . 2 4 . 4 12-30
88
Table 6
Correlations Among Quality of Life Measures (N=67)
ACT PRQ PGWSB QLI
.04 .16 .05
.33* .44**
.51***
* p <.01 
** £ <.001 
*** e  <-0001
ACT
PRQ
PGWSB
QLI
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Table 7
Correlations Among Compliance Measures (N=67)
BUN K IWG
BUN .49** .20
K . 34*
IWG
* p < .01 
** pc.0001
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Table 8
Correlations Between Compliance Measures and Quality of Life 
(N=67)
BUN K IWG
PRQ . 124 -.112 .031
PGWBS . 167 . 019 -.107
QLI 152 -. 113 -. 175
KAS .236 .273 .33*
* p c . 0 1
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Table 9
Correlations Among Medical/Demographic Variables and Quality 
of Life (N=67)
KAS PRQ PGWBS QLI
Sex .21 . 07 -.05 .08
Age -.59*** .30 . 13 . 24
Age Began -.61*** .33* . 09 .26
Years On . 10 -.11 . 14 - . 08
# Diagnoses -.45** . 06 -. 11 - . 10
* p <.01 
** £  <-001 
*** p <-0001
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Table 10
Compliance Variables Predicting Quality of Life Variables
Quality of Life
Variable____________ Regression Results
QLI R-squared (3,61) = . 05, ns
PGWBS R-squared (3,61) = .04, ns
PRQ R-Squared (3,61) = . 06 , ns
KAS R-squared (3,61) = .14, ns
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Table 11
Medical Demographic Variables Predicting Quality of Life 
Variables
Quality of Life
Variable________Regression Results
QLI R-squared (3,61) = .09, ns
PGWBS R-squared (3,61) = .06, ns
PRQ R-squared (3,61) = .11, ns
KAS R-squared (3,61) = .48, P, < .0001
Predictors Beta E <
Age dialysis began -.53 . 0001
Years on dialysis . 01 ns
Concurrent diagnoses -.34 . 001
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Table 12
Medical/Demographic and Compliance Variables Predicting
Quality of Life
Quality of Life
Variable___________Regression Results
QLI R-squared (6,58) = .14, ns
PGWBS R-squared (6,58) = .09, ns
PRQ R-squared (6,58) = .18, ns
KAS R-squared (6,58) = .50, E <.0001
Predictors Beta E <
Age dialysis began -.49 . 0001
Years on dialysis . 01 ns
Concurrent diagnoses -.31 . 01
BUN . 08 ns
K .05 ns
IWG . 10 ns
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Table 13
Canonical Correlation: Compliance and Quality of Life
No. Canonical R Eigenvalue Approx F Df U
1 . 51 . 36 2.43 12,153.7 . 006
2 . 32 . 12 1. 57 6, 118 . 16
3 . 20 . 04 1.30 2 , 60 .28
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Table 14
Canonical Correlation Weights and Loadings for Compliance 
and Quality of Life
Variables Canonical Weights Canonical Loadings 
(First Factor)
COMPLIANCE
BUN . 82 . 88
K -.13 . 44
IWG . 50 . 66
QUALITY OF LIFE
ACT . 66 . 64
PRQ . 55 .24
PGWBS .31 . 15
QLI . 89 -.44
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Table 15
Canonical Redundancy Analysis
Canonical Variate Squared Multiple Correlation
Quality of Life Compliance Factor
ACT . 1076
PRQ .0156
PGWBS . 0056
QLI . 0526
Compliance Quality of Life Factor
BUN . 2082
K . 0521
IWG .1151
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APPENDIX A
Informed Consent
I, _______________________________ , freely and willingly
consent to be a participate in a research project 
investigating Quality of Life in hemodialysis patients. As 
a research subject, I agree to complete 4 paper and pencil 
questionnaires that deal with my feelings about my health 
and well-being and quality of life. Additionally, I agree 
to allow the researchers, Linda S. Dietz, M.A. and Charlotte 
Jenkins, R.N., to review any of my pertinent medical 
records. I understand that there are no risks involved by 
participating in this project.
I understand that I may withdraw from participation in 
this study at any time with no adverse consequences. In 
addition, any information I provide during this project will 
be kept in strict confidence, and if this information is 
presented publicly (i.e., conferences, journal articles), no 
information will be identified with me personally.
I realize that I have the right to ask questions at any 
time and to have these questions answered to my 
satisfaction. I have read and thoroughly understand this 
consent form.
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APPENDIX B
Demographic/Medical Data
Patient's Name __________________________________
Age ________ Sex   Race_________
Current job status ___________  Occupation________
Source of Income ____________  Education_________
Living Arrangements __________________
Primary Medical Diagnosis
(Renal) (Other medical Dx)
Current Dialysis:
Relevant Treatment History (e.g. renal transplant failure, 
etc. ,)__________________________________________________________
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APPENDIX C
Compliance Criteria
1. Excellent. Weight gain between dialysis is never above 
500g. Predialysis serum potassium levels are never above 6 
mEq/liter and most of the time less. Predialysis BUN 
levels are steady.
2. Good. Weight gain between dialysis is from 500 to 1000 
g. Predialysis potassium levels are usually 6 mEq/liter. 
Predialysis BUN levels are usually steady but may show 
occasional j umps.
3. Fair. Weight gain between dialysis is mostly 1000 to 
1500 g rarely going up to 2 000 g. Predialysis potassium 
levels are from 6.0 to 6.8 mEq/liter.
4. Some abuse. Weight gain between dialysis is always above 
2000 g or most of the time above 2500 g. Predialysis 
potassium levels are frequently above 7.0 mEq/liter.
5. Great abuse. Weight gain between dialysis is always 
above 2000 g or most of the time above 2500 g. Predialysis 
potassium levels are frequently above 7.o mEq/liter.
Taken from Kaplan De-Nour, A., & Czaczkes, J.W. (1972). 
Personality factors in chronic hemodialysis patients causing 
noncompliance with the medical regimen. Psychosomatic 
Medicine, 31, 333-344.
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APPENDIX D
Karnofsky Activity Scale
Please rate _________________________ *s functional status on
the following scale:
Able to carry on normal activity; No special care needed: 
100% Normal; con complaints; no evidence of disease 
90% Able to carry on normal activity; minor signs or 
symptoms of disease 
80% Normal activity with effort; some signs or symptoms 
of disease
Unable to work; able to live at home; care for most personal 
needs; a varying amount of assistance:
70% Cares for self; unable to carry on normal activity
or to do active work
60% Requires occasional assistance but is able to care
for most of his needs 
50% Requires considerable assistance and frequent
medical care
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APPENDIX D (cont.)
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Unable to care for self; requires equivalent of 
institutional or hospital care; disease me be progressing 
rapidly:
40% Disabled; requires special care and assistance 
30% Severely disabled; hospitalization is indicated 
though death not imminent 
20% Very sick; hospitalization necessary; active 
supportive treatment is necessary
APPENDIX E
Interview Questions for the Karnofsky 
INSTRUCTIONS
Please ask the patient the following questions before 
completing the Karnofsky Activity Scale.
1. Have you had any weight loss or weight gain?
2. Have you had any decrease in energy or increase in
fatigue?
3. Have you had any difficulty grooming or bathing?
4. Have you had any difficulty driving?
5. Have you had any difficulty in walking or moving about?
6. Have you had any difficulty working full or part-time?
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